UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
MARK
ONE
☒
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for
the Quarterly Period ended September 30, 2023;
☐
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for
the transition period from ________ to ________
ZION OIL & GAS, INC. – File Number
001-33228
(Exact
name of registrant as specified in its charter)
Delaware | | 20-0065053 |
(State or other jurisdiction of | | (I.R.S. Employer |
incorporation or organization) | | Identification No.) |
12655 N Central Expressway, Suite 1000, Dallas, TX | | 75243 |
(Address of principal executive offices) | | Zip Code |
(214)
221-4610
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
N/A | | N/A | | N/A |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
| | Emerging growth company | ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
☒
As of November 7, 2023, Zion Oil & Gas, Inc. had outstanding 605,319,057
shares of common stock, par value $0.01 per share.
INDEX
PAGE
Zion
Oil & Gas, Inc.
Consolidated
Condensed Balance Sheets as of
| |
September 30, 2023 | | |
December 31, 2022 | |
| |
US$ thousands | | |
US$ thousands | |
| |
(Unaudited) | | |
| |
Current assets | |
| | |
| |
Cash and cash equivalents | |
| 510 | | |
| 1,735 | |
Fixed short term bank and escrow deposits – restricted | |
| 1,020 | | |
| 1,379 | |
Prepaid expenses and other current assets | |
| 233 | | |
| 600 | |
Other deposits | |
| - | | |
| 483 | |
Governmental receivables | |
| 10 | | |
| 267 | |
Other receivables | |
| 156 | | |
| 143 | |
Total current assets | |
| 1,929 | | |
| 4,607 | |
| |
| | | |
| | |
Unproved oil and gas properties, full cost method (see Note 4) | |
| 16,342 | | |
| 15,889 | |
| |
| | | |
| | |
Property and equipment at cost | |
| | | |
| | |
Drilling rig and related equipment, net of accumulated depreciation of $2,025 and $1,455 (see note 2I) | |
| 5,700 | | |
| 6,281 | |
Property and equipment, net of accumulated depreciation of $678 and $647 | |
| 81 | | |
| 112 | |
| |
| 5,781 | | |
| 6,393 | |
| |
| | | |
| | |
Right of Use Lease Assets (see Note 5) | |
| 246 | | |
| 202 | |
| |
| | | |
| | |
Other assets | |
| | | |
| | |
Assets held for severance benefits | |
| 436 | | |
| 424 | |
Total other assets | |
| 436 | | |
| 424 | |
| |
| | | |
| | |
Total assets | |
| 24,734 | | |
| 27,515 | |
| |
| | | |
| | |
Liabilities and Stockholders’ Equity | |
| | | |
| | |
| |
| | | |
| | |
Current liabilities | |
| | | |
| | |
Accounts payable | |
| 862 | | |
| 2,147 | |
Lease obligation – current (see Note 5) | |
| 192 | | |
| 196 | |
Asset retirement obligation | |
| 571 | | |
| 571 | |
Accrued liabilities | |
| 412 | | |
| 1,032 | |
Total current liabilities | |
| 2,037 | | |
| 3,946 | |
| |
| | | |
| | |
Long-term liabilities | |
| | | |
| | |
Lease obligation – non-current (see Note 5) | |
| 53 | | |
| 12 | |
Provision for severance pay | |
| 467 | | |
| 457 | |
Total long-term liabilities | |
| 520 | | |
| 469 | |
| |
| | | |
| | |
Total liabilities | |
| 2,557 | | |
| 4,415 | |
| |
| | | |
| | |
Commitments and contingencies (see Note 6) | |
| | | |
| | |
| |
| | | |
| | |
Stockholders’ equity | |
| | | |
| | |
Common stock, par value $.01; Authorized: 1,200,000,000 shares at September 30, 2023: Issued and outstanding: 602,554,266 and 524,231,493 shares at September 30, 2023 and December 31, 2022, respectively | |
| 6,026 | | |
| 5,242 | |
Additional paid-in capital | |
| 300,969 | | |
| 296,460 | |
Accumulated deficit | |
| (284,818 | ) | |
| (278,602 | ) |
Total stockholders’ equity | |
| 22,177 | | |
| 23,100 | |
| |
| | | |
| | |
Total liabilities and stockholders’ equity | |
| 24,734 | | |
| 27,515 | |
The
accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Statements of Operations (Unaudited)
| |
For the three months ended | | |
For the nine months ended | |
| |
September 30, | | |
September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
| |
(Unaudited) | | |
(Unaudited) | | |
(Unaudited) | | |
(Unaudited) | |
General and administrative | |
| 1,332 | | |
| 1,636 | | |
| 4,106 | | |
| 4,621 | |
Post impairment of unproved oil and gas properties | |
| 36 | | |
| - | | |
| 129 | | |
| - | |
Other | |
| 379 | | |
| 719 | | |
| 1,978 | | |
| 2,376 | |
Loss from operations | |
| (1,747 | ) | |
| (2,355 | ) | |
| (6,213 | ) | |
| (6,997 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income (expense), net | |
| | | |
| | | |
| | | |
| | |
Foreign exchange gain (loss) | |
| 2 | | |
| (2 | ) | |
| (2 | ) | |
| (92 | ) |
Financial income (expenses), net | |
| 2 | | |
| (17 | ) | |
| (1 | ) | |
| (48 | ) |
| |
| | | |
| | | |
| | | |
| | |
Loss, before income taxes | |
| (1,743 | ) | |
| (2,374 | ) | |
| (6,216 | ) | |
| (7,137 | ) |
Income taxes | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
| (1,743 | ) | |
| (2,374 | ) | |
| (6,216 | ) | |
| (7,137 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss per share of common stock | |
| | | |
| | | |
| | | |
| | |
Basic and diluted (in US$) | |
| (0.003 | ) | |
| (0.01 | ) | |
| (0.011 | ) | |
| (0.02 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding | |
| | | |
| | | |
| | | |
| | |
Basic and diluted (in thousands) | |
| 578,497 | | |
| 484,678 | | |
| 551,551 | | |
| 454,890 | |
The
accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Statement of Changes in Stockholders’ Equity (Unaudited)
For
the three and nine months ended September 30, 2023
| |
Common Stock | | |
Additional paid-in | | |
Accumulated | | |
| |
| |
Shares | | |
Amounts | | |
Capital | | |
deficit | | |
Total | |
| |
thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Balances as of December 31, 2022 | |
| 524,231 | | |
| 5,242 | | |
| 296,460 | | |
| (278,602 | ) | |
| 23,100 | |
Funds received from sale of DSPP units and shares and exercise of warrants | |
| 78,173 | | |
| 782 | | |
| 4,186 | | |
| — | | |
| 4,968 | |
Funds received from option exercises | |
| 150 | | |
| 2 | | |
| 10 | | |
| — | | |
| 12 | |
Costs associated with the issuance of shares | |
| — | | |
| — | | |
| (610 | ) | |
| — | | |
| (610 | ) |
Value of options granted to employees, directors and others as non-cash compensation | |
| — | | |
| — | | |
| 923 | | |
| — | | |
| 923 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (6,216 | ) | |
| (6,216 | ) |
Balances as of September 30, 2023 | |
| 602,554 | | |
| 6,026 | | |
| 300,969 | | |
| (284,818 | ) | |
| 22,177 | |
* |
Less
than one thousand. |
| |
Common Stock | | |
Additional paid-in | | |
Accumulated | | |
| |
| |
Shares | | |
Amounts | | |
Capital | | |
deficit | | |
Total | |
| |
thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Balances as of June 30, 2023 | |
| 560,449 | | |
| 5,604 | | |
| 299,321 | | |
| (283,075 | ) | |
| 21,850 | |
Funds received from sale of DSPP units and shares and exercise of warrants | |
| 42,105 | | |
| 422 | | |
| 1,820 | | |
| — | | |
| 2,242 | |
Funds received from option exercises | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Costs associated with the issuance of shares | |
| — | | |
| — | | |
| (437 | ) | |
| — | | |
| (437 | ) |
Value of options granted to employees, directors and others as non-cash compensation | |
| — | | |
| — | | |
| 265 | | |
| — | | |
| 265 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (1,743 | ) | |
| (1,743 | ) |
Balances as of September 30, 2023 | |
| 602,554 | | |
| 6,026 | | |
| 300,969 | | |
| (284,818 | ) | |
| 22,177 | |
For
the three and nine months ended September 30, 2022
| |
Common Stock | | |
Additional paid-in | | |
Accumulated | | |
| |
| |
Shares | | |
Amounts | | |
Capital | | |
deficit | | |
Total | |
| |
thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Balances as of December 31, 2021 | |
| 364,324 | | |
| 3,643 | | |
| 277,258 | | |
| (223,525 | ) | |
| 57,376 | |
Funds received from sale of DSPP units and shares and exercise of warrants | |
| 132,451 | | |
| 1,325 | | |
| 15,145 | | |
| — | | |
| 16,470 | |
Funds received from option exercises | |
| 325 | | |
| 3 | | |
| — | | |
| — | | |
| 3 | |
Value of options granted to employees, directors and others as non-cash compensation | |
| — | | |
| — | | |
| 1,154 | | |
| — | | |
| 1,154 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (7,137 | ) | |
| (7,137 | ) |
Balances as of September 30, 2022 | |
| 497,100 | | |
| 4,971 | | |
| 293,557 | | |
| (230,662 | ) | |
| 67,866 | |
| |
Common Stock | | |
Additional paid-in | | |
Accumulated | | |
| |
| |
Shares | | |
Amounts | | |
Capital | | |
deficit | | |
Total | |
| |
thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Balances as of June 30, 2022 | |
| 473,778 | | |
| 4,738 | | |
| 289,792 | | |
| (228,288 | ) | |
| 66,242 | |
Funds received from sale of DSPP units and shares and exercise of warrants | |
| 23,102 | | |
| 231 | | |
| 3,246 | | |
| — | | |
| 3,477 | |
Funds received from option exercises | |
| 220 | | |
| 2 | | |
| — | | |
| — | | |
| 2 | |
Value of options granted to employees, directors and others as non-cash compensation | |
| — | | |
| — | | |
| 519 | | |
| — | | |
| 519 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (2,374 | ) | |
| (2,374 | ) |
Balances as of September 30, 2022 | |
| 497,100 | | |
| 4,971 | | |
| 293,557 | | |
| (230,662 | ) | |
| 67,866 | |
* |
Less
than one thousand. |
The
accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Statements of Cash Flows (Unaudited)
| |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | |
| |
US$ thousands | | |
US$ thousands | |
| |
(Unaudited) | | |
(Unaudited) | |
Cash flows from operating activities | |
| | |
| |
Net loss | |
| (6,216 | ) | |
| (7,137 | ) |
Adjustments required to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Depreciation | |
| 601 | | |
| 593 | |
Cost of options issued to employees, directors and others as non-cash compensation | |
| 923 | | |
| 1,137 | |
Post impairment of unproved oil and gas properties | |
| 129 | | |
| - | |
Change in assets and liabilities, net: | |
| | | |
| | |
Other deposits | |
| 483 | | |
| 73 | |
Prepaid expenses and other | |
| 367 | | |
| 196 | |
Governmental receivables | |
| 257 | | |
| 631 | |
Lease obligation – current | |
| (256 | ) | |
| (112 | ) |
Lease obligation – non current | |
| 41 | | |
| (122 | ) |
Right of use lease assets | |
| 208 | | |
| 194 | |
Other receivables | |
| (13 | ) | |
| 95 | |
Severance payable, net | |
| (2 | ) | |
| 24 | |
Accounts payable | |
| (300 | ) | |
| (350 | ) |
Accrued liabilities | |
| (131 | ) | |
| 59 | |
Net cash used in operating activities | |
| (3,909 | ) | |
| (4,719 | ) |
| |
| | | |
| | |
Cash flows from investing activities | |
| | | |
| | |
Acquisition of property and equipment | |
| - | | |
| (17 | ) |
Acquisition of drilling rig and related equipment | |
| - | | |
| (373 | ) |
Investment in unproved oil and gas properties | |
| (2,045 | ) | |
| (12,943 | ) |
Net cash used in investing activities | |
| (2,045 | ) | |
| (13,333 | ) |
| |
| | | |
| | |
Cash flows from financing activities | |
| | | |
| | |
Proceeds from exercise of stock options | |
| 12 | | |
| 3 | |
Costs paid related to the issuance of new shares | |
| (610 | ) | |
| - | |
Proceeds from issuance of stock and exercise of warrants | |
| 4,968 | | |
| 16,470 | |
Net cash provided by financing activities | |
| 4,370 | | |
| 16,473 | |
| |
| | | |
| | |
Net (decrease)/increase in cash, cash equivalents and restricted cash | |
| (1,584 | ) | |
| (1,579 | ) |
Cash, cash equivalents and restricted cash – beginning of period | |
| 3,114 | | |
| 5,952 | |
Cash, cash equivalents and restricted cash – end of period | |
| 1,530 | | |
| 4,373 | |
| |
| | | |
| | |
Supplemental schedule of cash flow information | |
| | | |
| | |
| |
| | | |
| | |
Non-cash investing and financing activities: | |
| | | |
| | |
Unpaid investments in oil & gas properties | |
| 677 | | |
| 2,723 | |
Cost of options issued to employees attributed to oil and gas properties | |
| - | | |
| 17 | |
New lease accounted for as a right of use lease asset | |
| 252 | | |
| 136 | |
The
accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Cash,
cash equivalents and restricted cash, are comprised as follows:
| |
September 30, 2023 | | |
September 30, 2022 | |
| |
US$ thousands | | |
US$ thousands | |
Cash and cash equivalents | |
| 510 | | |
| 3,079 | |
Restricted cash included in fixed short-term bank deposits | |
| 1,020 | | |
| 1,294 | |
| |
| 1,530 | | |
| 4,373 | |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
1 - Nature of Operations, Basis of Presentation and Going Concern
A.
Nature of Operations
Zion
Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is
an oil and gas exploration company with a history of 23 years of oil & gas exploration in Israel. As of September 30, 2023, the Company
has no revenues from its oil and gas operations.
Zion
maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland.
The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is
to operate a foreign treasury center for the Company.
On
January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning
a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling
Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for
its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market
rates then in effect.
Zion
has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed
with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition,
Zion has the trademark filed with the Israeli Trademark Office in Israel.
Exploration
Rights/Exploration Activities
New
Megiddo Valleys License 434 (“NMVL 434”)
The
New Megiddo License 428 (“NML 428”) was initially awarded on December 3, 2020 for a six-month term and was extended several
times before expiring on February 1, 2023. Zion Oil & Gas, Inc. filed an amended application with the Israel Ministry of Energy for
a new exploratory license on January 24, 2023 covering the same area as its License No. 428, which expired on February 1, 2023. However,
its original application to replace License No. 428 was filed on May 11, 2022, and a revised application was filed on August 29, 2022.
On
September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil
and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 will be valid for three years
until September 13, 2026 with four 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes
our previous NML 428.
We
continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum
system with significant exploration potential.
Zion is deploying new technologies, focusing on new stimulation methods
for MJ-01, and aiming to potentially unlock hydrocarbon flows in several identified key zones. Zion has already procured service contractors
and ancillary items required for efficient operations. Zion must receive approval of its work plan from the Ministry of Energy prior to
commencing its re-completion activities. Zion’s planned activities are currently suspended as a result of the Israel-Hamas war (See
Subsequent Events for further insight).
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
1 - Nature of Operations, Basis of Presentation and Going Concern (cont’d)
B.
Basis of Presentation
The
accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance
with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information
and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for
complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary
for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this
Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the
Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The year-end balance sheet data presented for comparative
purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations
for the three and nine months ended September 30, 2023 are not necessarily indicative of the operating results for the year ending December
31, 2023 or for any other subsequent interim period.
C.
Going Concern
The
Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way
of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial
production of hydrocarbons.
The Company’s ability to continue as a going
concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately
generating profitable operations from its oil and natural gas interests in the future. While the Company is still actively engaging service
providers in planning activities for the re-completion of the MJ-01 well, our activities are temporarily suspended due to the Israel-Hamas
war. War was declared by Israel on Hamas following the October 7, 2023 invasion by Hamas in southern Israel. It is not known how long
this war will last and, therefore, we cannot predict with certainty when our exploration activities will resume. The Company’s current
operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s
estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern
may be impaired. The consolidated financial statements have been prepared on a going concern basis, which contemplates realization of
assets and liquidation of liabilities in the ordinary course of business. During the nine months ended September 30, 2023, the Company
incurred a net loss of approximately $6.2 million and had an accumulated deficit of approximately $285 million. These factors raise substantial
doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.
To
carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable
operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is
not, the Company may be forced to curtail or cease exploration and development activities. The consolidated financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
2 - Summary of Significant Accounting Policies
A.
Net Loss per Share Data
Basic
and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with
ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 53,556,910
and 56,438,572 and 53,985,877 and 41,395,169 Common Stock equivalents in the three and nine-month period ended September 30, 2023 and
2022 respectively, would be anti-dilutive.
B.
Use of Estimates
The preparation of the accompanying consolidated
financial statements in conformity with accounting principles generally accepted in the United States of America requires management to
make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities
reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation
of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases
accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management
evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors. The Company adjusts such estimates
and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, regional hostilities
and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects
cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting
from continuing changes in the economic and operating environment will be reflected in the consolidated financial statements in future
periods.
See comments in our Subsequent Events for the
impact of the Israel-Hamas war on our business and future operations.
C.
Oil and Gas Properties and Impairment
The
Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration
and development of oil and gas reserves, including directly related overhead costs, are capitalized.
All
capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production
method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until
proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that
the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the
adjusted carrying amount of the proved properties is amortized on the unit-of-production method.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
2 - Summary of Significant Accounting Policies (cont’d)
The
Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost
pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least
quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet
been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling
rights or other information.
During
the fourth quarter of 2022, the Company testing protocol was concluded at the MJ-02 well. The test results confirmed that the MJ-02 well
did not contain hydrocarbons in commercial quantities in the zones tested. As a result, in the year ended December 31, 2022, the Company
recorded a non-cash impairment charge to its unproved oil and gas properties of $45,615,000.
During
the three and nine months ended September 30, 2023, the Company recorded post-impairment charges of $36,000 and $129,000, respectively.
During the three and nine months ended September 30, 2022, the Company did not record any post-impairment charges.
Currently,
the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist
of capitalized exploration costs of $16,342,000 and $15,889,000 as of September 30, 2023 and December 31, 2022, respectively.
D.
Fair Value Measurements
The
Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial
Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s
financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC
820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature
of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or
paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction
occurs in the principal or most advantageous market for that asset or liability.
The
Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring
basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.
The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining
fair value. The three tiers are defined as follows:
|
● |
Level
1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; |
|
● |
Level
2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace
for identical or similar assets and liabilities; and |
|
● |
Level
3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. |
The
Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at
historical cost. At September 30, 2023, and December 31, 2022, the carrying amounts of these instruments approximated their fair values
because of the short-term nature of these instruments.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
2 - Summary of Significant Accounting Policies (cont’d)
E.
Stock-Based Compensation
ASC
718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment
transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares,
options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees,
including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on
their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for
the award, known as the requisite service period (usually the vesting period).
The
Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 718
Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable:
(a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined
at the earlier of the performance commitment date or performance completion date.
F.
Warrants
In
connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued
warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily
redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes
option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded
and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded
at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted
in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.
G.
Related parties
Parties
are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are
controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management,
members of the immediate families of principal owners of the Company and its management and other parties with which the Company may
deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of
the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are
recorded at fair value of the goods or services exchanged.
Zion
did not have any related party transactions for the periods covered in this report.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
2 - Summary of Significant Accounting Policies (cont’d)
H.
Recently Adopted Accounting Pronouncements
In
March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update
are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected
to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification
to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand
and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies
for fiscal years beginning after December 15, 2022 with early application permitted. Zion adopted ASU 2020-03 in the first quarter of
2023. The adoption of this ASU did not have any impact on its consolidated financial statements.
In
October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers. The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize
and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to
the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including
contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU
results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree
before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted.
Zion adopted ASU 2021-08 in the first quarter of 2023. The adoption of this ASU did not have a material impact on our consolidated financial
statements; the impact in future periods will be dependent upon the contract assets acquired and contract liabilities assumed in any
future business combinations.
In
September 2022, the FASB issued ASU No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The ASU requires
companies to disclose information about supplier finance programs, including key terms of the program, outstanding confirmed amounts
as of the end of the period, a roll forward of such amounts during each annual period, and a description of where the amounts are presented.
The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance obligations. The
ASU is effective for fiscal years beginning after December 15, 2022, including interim periods, except for roll forward information,
which is effective for fiscal years beginning after December 15, 2023. The adoption of this ASU did not have any impact on its consolidated
financial statements.
Other
Recent Accounting Pronouncements
The
Company does not believe that the adoption of any recently issued accounting pronouncements in 2023 had a significant impact on our consolidated
financial position, results of operations, or cash flow.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
2 - Summary of Significant Accounting Policies (cont’d)
I.
Depreciation and Accounting for Drilling Rig and Related Equipment
Zion
purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million
in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value
of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig
on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating
the rig on a straight-line basis.
Zion
uses the First In First Out (“FIFO”) method of accounting for the inventory of spare parts, meaning that the earliest items
purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.
It
is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that
the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling
rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and
our straight-line amortization will be adjusted accordingly.
See
the table below for a reconciliation of the rig-related activity during the nine months ended September 30, 2023:
I-35
Drilling Rig & Associated Equipment:
| |
As of September 30, 2023 | |
| |
I-35 Drilling Rig | | |
Rig Spare Parts | | |
Other Drilling Assets | | |
Total | |
| |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
December 31, 2022 | |
| 5,225 | | |
| 619 | | |
| 437 | | |
| 6,281 | |
Asset Additions | |
| - | | |
| - | | |
| - | | |
| - | |
Asset Depreciation | |
| (476 | ) | |
| - | | |
| (94 | ) | |
| (570 | ) |
Asset Disposals for Self-Consumption | |
| - | | |
| (11 | ) | |
| - | | |
| (11 | ) |
September 30, 2023 | |
| 4,749 | | |
| 608 | | |
| 343 | | |
| 5,700 | |
During
the nine months ended September 30, 2023 and 2022, the Company had depreciation expense of $570,000 and $560,000, respectively. During the three months ended September 30, 2023 and 2022, the Company
had depreciation expense of $190,000 and $189,000, respectively. The asset
disposal due to self-consumption was not material during the periods.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity
The
Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase
the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000
shares, effective June 7, 2023.
A.
2021 Omnibus Incentive Stock Option Plan
Effective
June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option
Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares
of common stock.
The
Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock,
bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments
under certain conditions.
The
compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award,
when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable
for a period not to exceed ten years from the date of grant.
During
the nine months ended September 30, 2023, the Company granted the following options from the 2021 Equity Omnibus Plan for employees,
directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000. |
| ii. | Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500. |
| iii. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through June 8, 2033. The fair value of the options at the date of grant amounted to approximately $1,500. |
| iv. | Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $600. |
| v. | Options to purchase 895,000 shares of Common Stock to five staff members and one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $60,000. |
| | |
| vi. | Options to purchase 3,350,000 shares of Common Stock to four senior officers and nine staff members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $211,000, and will be recognized during the years 2023 and 2024. |
| | |
| vii. | Options to purchase 3,600,000 shares of Common Stock to nine board members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $227,000, and will be recognized during the years 2023 and 2024. |
| | |
| viii. | Options to purchase 55,000 shares of Common Stock to three consultants at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $3,000, and will be recognized during the years 2023 and 2024. |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
During
the nine months ended September 30, 2022, the Company granted the following options from the 2021 Equity Omnibus Plan for employees,
directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase 175,000 shares of Common Stock to six senior officers and one staff member at an exercise price of $0.1529 per share. The options vested upon grant and are exercisable through January 4, 2032. The fair value of the options at the date of grant amounted to approximately $22,000. |
| ii. | Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $4,000. |
| iii. | Options to purchase 300,000 shares of Common Stock to one senior officer and one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,000. |
| iv. | Options to purchase 200,000 shares of Common Stock to one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $29,000. |
| v. | Options to purchase 1,600,000 shares of Common Stock to five senior officers and four staff members at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $209,000, and will be recognized during the years 2022 and 2023. |
| vi. | Options to purchase 1,400,000 shares of Common Stock to seven board members, at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $182,000, and will be recognized during the years 2022 and 2023. |
| | |
| vii. | Options to purchase 160,000 shares of Common Stock to four staff members, at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 17, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $23,000. |
| | |
| viii. | Options to purchase 200,000 shares of Common Stock to six staff members at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $26,000, and will be recognized during the years 2022 and 2023. |
| | |
| ix. | Options to purchase 40,000 shares of Common Stock to two consultants at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $5,000, and will be recognized during the years 2022 and 2023. |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
| x. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.11 per share. The options vested upon grant and are exercisable through April 1, 2032. The fair value of the options at the date of grant amounted to approximately $2,000. |
| xi. | Options to purchase 3,210,000 shares of Common Stock to five senior officers, two consultants and ten staff members at an exercise price of $0.15 per share. The options vested on April 15, 2023 (in one year) and are exercisable through April 15, 2032. The fair value of the options at the date of grant amounted to approximately $394,000, and will be recognized during the years 2022 and 2023. |
| xii. | Options to purchase 1,090,000 shares of Common Stock to one senior officer, one board member and five staff members at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $149,000. |
| xiii. | Options to purchase 3,200,000 shares of Common Stock to eight board members at an exercise price of $0.15 per share. The options vested on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $393,000. |
| xiv. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.2350 per share. The options vested upon grant and are exercisable through August 1, 2032. The fair value of the options at the date of grant amounted to approximately $5,000. |
| xv. | Options to purchase 118,000 shares of Common Stock to two senior officers and four staff members at an exercise price of $0.2350 per share. The options vested upon grant and are exercisable through August 12, 2032. The fair value of the options at the date of grant amounted to approximately $29,000. |
| | |
| xvi. | Options to purchase 75,000 shares of Common Stock to four staff members and one consultant at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through August 12, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $13,000. |
| | |
| xvii. | Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 01, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $2,000. |
| | |
| xviii. | Options to purchase 2,455,000 shares of Common Stock to four senior officers and thirteen staff members at an exercise price of $0.1797 per share. The options vest on September 23, 2023 (one year from the date of grant) and are exercisable through September 23, 2032. The fair value of the options at the date of grant amounted to approximately $396,000, and will be recognized during the years 2022 and 2023. |
| | |
| xix. | Options to purchase 2,700,000 shares of Common Stock to nine board members at an exercise price of $0.1797 per share. The options vest on September 23, 2023 (one year from the date of grant) and are exercisable through September 23, 2023. The fair value of the options at the date of grant amounted to approximately $436,000, and will be recognized during the years 2022 and 2023. |
| | |
| xx. | Options to purchase 845,000 shares of Common Stock to one senior officer, one board member and four staff members at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $149,000. |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
B.
Stock Options
The
stock option transactions since January 1, 2023 are shown in the table below:
| |
Number of shares | | |
Weighted Average exercise price | |
| |
| | |
US$ | |
Outstanding, December 31, 2022 | |
| 26,391,250 | | |
| 0.30 | |
| |
| | | |
| | |
Changes during 2023 to: | |
| | | |
| | |
Granted to employees, officers, directors and others | |
| 8,135,000 | | |
| 0.07 | |
Expired/Cancelled/Forfeited | |
| (275,000 | ) | |
| 1.71 | |
Exercised | |
| (150,000 | ) | |
| 0.07 | |
Outstanding, September 30, 2023 | |
| 34,101,250 | | |
| 0.23 | |
Exercisable, September 30, 2023 | |
| 27,096,250 | | |
| 0.27 | |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
The
following table summarizes information about stock options outstanding as of September 30, 2023:
Shares
underlying outstanding options (non-vested) |
|
|
Shares
underlying outstanding options (fully vested) |
|
Range
of
exercise
price |
|
|
Number
outstanding |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Weighted
Average
Exercise
price |
|
|
Range
of
exercise
price |
|
|
Number
Outstanding |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Weighted
Average
Exercise
price |
|
US$ |
|
|
|
|
|
|
|
|
US$ |
|
|
US$ |
|
|
|
|
|
|
|
|
US$ |
|
|
0.07 |
|
|
|
7,005,000 |
|
|
|
9.99 |
|
|
|
0.07 |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
0.12 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
5,000 |
|
|
|
0.70 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
20,000 |
|
|
|
2.68 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
130,000 |
|
|
|
3.26 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
50,000 |
|
|
|
3.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
60,000 |
|
|
|
3.55 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
200,000 |
|
|
|
3.64 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
40,000 |
|
|
|
4.01 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
70,000 |
|
|
|
4.26 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
4.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
30,000 |
|
|
|
4.42 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
4,000 |
|
|
|
4.52 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
5.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
35,000 |
|
|
|
5.97 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
150,000 |
|
|
|
6.14 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
35,000 |
|
|
|
6.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
75,000 |
|
|
|
7.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
200,000 |
|
|
|
7.64 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
300,000 |
|
|
|
7.80 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
7.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
500,000 |
|
|
|
8.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
55,000 |
|
|
|
8.30 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
960,000 |
|
|
|
8.55 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
75,000 |
|
|
|
8.87 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
8.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
795,000 |
|
|
|
8.99 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
9.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
9.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
895,000 |
|
|
|
9.99 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.06 |
|
|
|
50,000 |
|
|
|
9.27 |
|
|
|
0.06 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.07 |
|
|
|
25,000 |
|
|
|
9.70 |
|
|
|
0.07 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.14 |
|
|
|
240,000 |
|
|
|
8.31 |
|
|
|
0.14 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.15 |
|
|
|
3,200,000 |
|
|
|
8.27 |
|
|
|
0.15 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.15 |
|
|
|
6,410,000 |
|
|
|
8.55 |
|
|
|
0.15 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.16 |
|
|
|
340,000 |
|
|
|
2.20 |
|
|
|
0.16 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.16 |
|
|
|
75,000 |
|
|
|
6.20 |
|
|
|
0.16 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.18 |
|
|
|
25,000 |
|
|
|
2.18 |
|
|
|
0.18 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.18 |
|
|
|
5,155,000 |
|
|
|
8.99 |
|
|
|
0.18 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.24 |
|
|
|
25,000 |
|
|
|
8.84 |
|
|
|
0.24 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.24 |
|
|
|
118,000 |
|
|
|
8.87 |
|
|
|
0.24 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.25 |
|
|
|
50,000 |
|
|
|
7.93 |
|
|
|
0.25 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.25 |
|
|
|
363,000 |
|
|
|
7.93 |
|
|
|
0.25 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.28 |
|
|
|
25,000 |
|
|
|
1.93 |
|
|
|
0.28 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.28 |
|
|
|
25,000 |
|
|
|
5.93 |
|
|
|
0.28 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.29 |
|
|
|
25,000 |
|
|
|
3.71 |
|
|
|
0.29 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.39 |
|
|
|
1,435,000 |
|
|
|
7.78 |
|
|
|
0.39 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.59 |
|
|
|
1,400,000 |
|
|
|
3.64 |
|
|
|
0.59 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.59 |
|
|
|
1,600,000 |
|
|
|
7.64 |
|
|
|
0.59 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.92 |
|
|
|
350,000 |
|
|
|
3.27 |
|
|
|
0.92 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.92 |
|
|
|
550,000 |
|
|
|
7.27 |
|
|
|
0.92 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.38 |
|
|
|
105,307 |
|
|
|
1.26 |
|
|
|
1.38 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.67 |
|
|
|
405,943 |
|
|
|
1.01 |
|
|
|
1.67 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.78 |
|
|
|
25,000 |
|
|
|
0.93 |
|
|
|
1.78 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2.31 |
|
|
|
250,000 |
|
|
|
0.25 |
|
|
|
2.31 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4.15 |
|
|
|
25,000 |
|
|
|
0.76 |
|
|
|
4.15 |
|
|
0.07 |
|
|
|
7,005,000 |
|
|
|
|
|
|
|
0.07 |
|
|
|
0.01-4.15 |
|
|
|
27,096,250 |
|
|
|
|
|
|
|
0.27 |
|
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
Granted
to employees
The
following table sets forth information about the weighted-average fair value of options granted to employees and directors during the
year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
| |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | |
Weighted-average fair value of underlying stock at grant date | |
$ | 0.07 | | |
$ | 0.16 | |
Dividend yields | |
| — | | |
| — | |
Expected volatility | |
| 135%-137 | % | |
| 127%-135 | % |
Risk-free interest rates | |
| 3.85%-4.61 | % | |
| 1.37%-3.96 | % |
Expected lives (in years) | |
| 5.00-5.50 | | |
| 5.00-5.50 | |
Weighted-average grant date fair value | |
$ | 0.06 | | |
$ | 0.14 | |
Granted
to non-employees
The
following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using
the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
| |
For the nine months ended
September 30, | |
| |
2023 | | |
2022 | |
Weighted-average fair value of underlying stock at grant date | |
| 0.07 | | |
$ | 0.16 | |
Dividend yields | |
| — | | |
| — | |
Expected volatility | |
| 134 | % | |
| 103% - 104 | % |
Risk-free interest rates | |
| 4.61 | % | |
| 1.78% - 2.84 | % |
Expected lives (in years) | |
| 10 | | |
| 10 | |
Weighted-average grant date fair value | |
| 0.06 | | |
$ | 0.15 | |
The
risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected
life of the options.
The
expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of
the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin
No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules,
as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees
equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended
life.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
C.
Compensation Cost for Warrant and Option Issuances
The
following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
264 |
|
|
|
510 |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
921 |
|
|
|
1,142 |
|
The
following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
8 |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
2 |
|
|
|
11 |
|
The
following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and
capitalized to Unproved Oil & Gas properties:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
— |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
17 |
|
The
following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and
capitalized to Unproved Oil & Gas properties:
As
of September 30, 2023, there was $431,000 of unrecognized compensation cost related to non-vested stock options granted under the Company’s
various stock option plans. That cost is expected to be recognized during the remaining periods of 2023 and 2024.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
D.
Dividend Reinvestment and Stock Purchase Plan (“DSPP”)
On
March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with
the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014.
On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration
No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The
Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed
and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and
replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.
On
March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders
and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly
from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original
Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration
Statement on Form S-3, as thereafter amended.
On
January 13, 2015, the Company amended the Original Prospectus Supplement (“Amendment No. 3”) to provide for a unit option
(the “Unit Option”) under the DSPP comprised of one share of Common Stock and three Common Stock purchase warrants with each
unit priced at $4.00. Each warrant afforded the participant the opportunity to purchase the Company’s Common Stock at a warrant
exercise price of $1.00. Each of the three warrants series had different expiration dates that had been extended.
The
ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018,
at a per share exercise price of $1.00.
As
of May 2, 2017, any outstanding ZNWAB warrants expired.
As
of May 2, 2018, any outstanding ZNWAC warrants expired.
On
May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020
to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2,
2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension.
As
of May 2, 2023, any outstanding ZNWAD warrants expired.
On
November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units
comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant
is referred to as “ZNWAE.”
The
ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of
$1.00.
On
May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020
to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1,
2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
As
of May 1, 2023, any outstanding ZNWAE warrants expired.
On
May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants,
a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions
and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase
Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common
Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common
Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares
of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.”
All
ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise
price of $1.00.
On
May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020
to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August
14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of August 14, 2023, any outstanding ZNWAF warrants expired.
An
Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017.
Under
Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants
to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of
shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s
Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15
shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”
The warrants became exercisable on January 8,
2018 and continue to be exercisable through January 8, 2023 at a revised per share exercise price of $.25. The warrant terms provide that
if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior
to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing
60 days advanced notice to the warrant holders.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
On
December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January
8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
On
February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units
of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase
warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares
of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase
one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”
The
warrants became exercisable on April 2, 2018 and continued to be exercisable through April 2, 2020 at a per share exercise price of $5.00,
after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April
2, 2019 to April 2, 2020.
On
May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 2, 2020
to April 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April
2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
As
of April 2, 2023, any outstanding ZNWAH warrants expired.
On
August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units
of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common
Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly
traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional
twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s
Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common
Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.”
The
warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price
of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date
of October 29, 2019 to October 29, 2020.
On
May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29,
2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October
29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
On
December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units
of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of
Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at
a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s
Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase
one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
The
warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price
of $0.01.
On
May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25,
2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February
25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of February 25, 2023, any outstanding ZNWAK warrants expired.
On
April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended
the termination date of the unit offering.
The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two
hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of
Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the
Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program
with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at
a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit
Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were
entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant
affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is
referred to as “ZNWAL.”
The
warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price
of $2.00.
On
September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August
26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of August 26, 2023, any outstanding ZNWAL warrants expired.
Under our Plan, the Company under a Request For
Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities
and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with
the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity
to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.”
The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable
on January 15, 2021 and continued to be exercisable through July 15, 2022.
On
March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022
to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such,
there is no value assigned to this extension.
On
June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion
considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the
termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per
ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the
number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase
an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited
with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants
who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments
(“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of
$1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers
to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the
Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $1.00. The warrant is referred to as “ZNWAN.”
The
warrants became exercisable on May 16, 2021 and continued to be exercisable through May 16, 2023 at a per share exercise price of $1.00.
As
of May 16, 2023, any outstanding ZNWAN warrants expired.
On
April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.
The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the
number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase
an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited
with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants
who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments
(“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price
of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers
to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the
Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $.25. The warrant is referred to as “ZNWAO.”
The
warrants became exercisable on June 12, 2021 and continued to be exercisable through June 12, 2023 at a per share exercise price of $.25.
As
of June 12, 2023, any outstanding ZNWAO warrants expired.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to
a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of
shares of the Company’s Common Stock that were acquired.
Under our Plan, the Company under a Request For
Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After
conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s
Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common
Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be
registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable
through July 15, 2023 at a revised per share exercise price of $.05.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
Zion
considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On August 21, 2023, the Company extended the termination
date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.
As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the
termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per
ASC 815-40-35-2. As such, there is no value assigned to this extension.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program
on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock
that were acquired.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation
of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised
per share exercise price of $.25.
On
December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose
of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus
that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein.
On
December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting
the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus
that forms a part of the Registration Statement and accordingly such prospectus has not been included herein.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation
of “ZNWAT.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per
share exercise price of $.25.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation
of “ZNWAU.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per
share exercise price of $.25.
Under our Plan, the Company under a Request For
Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program
on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that
were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed
two additional Waiver Term Sheets with the same participant consisting of shares of stock. After conclusion of the program on December
31, 2023, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock that were
acquired. During the quarter ended September 30, 2023, Zion incurred an additional $437,000 in equity issuance costs bringing the YTD
total to approximately $610,000.
On
March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December
15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock
Purchase Plan. This Amendment No. 2 to Prospectus Supplement amended the Prospectus Supplement. The Prospectus forms a part of the Company’s
Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15,
2021.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
Amendment
No. 2 - New Unit Option under the Unit Program
Under
our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants
with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment
No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This
Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total
of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13,
2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche
began on April 10, 2023 and terminated on April 27, 2023.
The
Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares
of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s
publicly traded common stock as reported on the OTCQX on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an
additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each
warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant
shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX”
under the third tranche.
Plan
participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly
Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price
of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the
Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they
purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received
one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and
fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY
warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to
participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.
The
ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price
of $0.05.
As
of June 28, 2023, any outstanding ZNWAV warrants expired.
The
ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price
of $0.05.
As
of July 13, 2023, any outstanding ZNWAW warrants expired.
The
ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price
of $0.05.
On
July 31, 2023, any outstanding ZNWAX warrants expired.
The
ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise
price of $0.05.
On
September 10, 2023, any outstanding ZNWAY warrants expired.
Amendment
No. 3 – New Unit Option under the Unit Program
Under
our Plan, provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.
Our
Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined
in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price
and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May
15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each)
was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average
of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQX on the Unit Purchase Date
and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price
of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants
that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common
Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered
for trading on the OTCQX or any other stock market or trading market.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
Plan
participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly
Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise
price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and
received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional
three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.
The ZNWAZ warrants became exercisable on July
17, 2023 and continue to be exercisable through July 17, 2024 at a per share exercise price of $0.25.
Amendment No. 4 – New Unit Option under
the Unit Program
Under our Plan, we are providing a Unit Option
under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and terminates on December 31, 2023.
Our Unit Program consists of the combination of
Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment
No. 1. Amendment No. 4 provides the option period, unit price and the determination of the number of shares of Common Stock and warrants
per unit. This Unit Option began on November 6, 2023 and is scheduled to terminate on December 31, 2023, unless extended at the sole discretion
of Zion Oil & Gas, Inc. The Unit Option consists of Units of our securities where each Unit (priced at $250.00 each) is comprised
of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and
low sale prices of the Company’s publicly traded common stock as reported on the OTCQX on the Unit Purchase Date and (ii) Common
Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s
Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units
purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQX or any
other stock market or trading market.
Plan participants, who enroll into the Unit Program
with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum
of $50.00 per month, will receive an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The
fifty (50) additional warrants are for enrolling into the AMI program and shall receive the above warrant with the Company notation of
“ZNWBA.” Existing subscribers to the AMI are entitled to the additional fifty (50) warrants, if they purchase at least one
(1) Unit during the Unit program.
The ZNWBA warrants will become exercisable on
January 15, 2024, unless extended, and continue to be exercisable through January 14, 2025, unless extended, at a per share exercise price
of $0.25.
For
the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program,
respectively. The $4,358,000 figure is net of $610,000 in equity issuance costs to an outside party.
For
the three and nine months ended September 30, 2022, approximately $3,477,000, and $16,470,000 were raised under the DSPP program,
respectively.
The company raised approximately $391,000 from the period October
1, 2023 through November 7, 2023, under the DSPP program.
The
warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other
warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification
and accounting purposes only.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
3 - Stockholders’ Equity (cont’d)
E.
Warrant Table
The
warrants balances at December 31, 2022 and transactions since January 1, 2023 are shown in the table below:
Warrants | |
Exercise Price | | |
Warrant Termination Date | |
Outstanding Balance, 12/31/2022 | | |
Warrants Issued | | |
Warrants Exercised | | |
Warrants Expired | | |
Outstanding Balance, 9/30/2023 | |
ZNWAA | |
$ | 2.00 | | |
01/31/2024 | |
| 1,498,804 | | |
| - | | |
| - | | |
| - | | |
| 1,498,804 | |
ZNWAD | |
$ | 1.00 | | |
05/02/2023 | |
| 243,853 | | |
| - | | |
| - | | |
| (243,853 | ) | |
| - | |
ZNWAE | |
$ | 1.00 | | |
05/01/2023 | |
| 2,144,099 | | |
| - | | |
| - | | |
| (2,144,099 | ) | |
| - | |
ZNWAF | |
$ | 1.00 | | |
08/14/2023 | |
| 359,435 | | |
| - | | |
| - | | |
| (359,435 | ) | |
| - | |
ZNWAG | |
$ | 1.00 | | |
01/08/2024 | |
| 240,068 | | |
| - | | |
| - | | |
| - | | |
| 240,068 | |
ZNWAH | |
$ | 5.00 | | |
04/19/2023 | |
| 372,400 | | |
| - | | |
| - | | |
| (372,400 | ) | |
| - | |
ZNWAI | |
$ | 3.00 | | |
06/29/2023 | |
| 640,710 | | |
| - | | |
| (100 | ) | |
| (640,610 | ) | |
| - | |
ZNWAJ | |
$ | 1.00 | | |
10/29/2023 | |
| 545,900 | | |
| - | | |
| - | | |
| - | | |
| 545,900 | |
ZNWAK | |
$ | 0.01 | | |
02/25/2023 | |
| 424,225 | | |
| - | | |
| (9,050 | ) | |
| (415,175 | ) | |
| - | |
ZNWAL | |
$ | 2.00 | | |
08/26/2023 | |
| 517,875 | | |
| - | | |
| - | | |
| (517,875 | ) | |
| - | |
ZNWAM | |
$ | 0.05 | | |
12/31/2023 | |
| 4,376,000 | | |
| - | | |
| - | | |
| - | | |
| 4,376,000 | |
ZNWAN | |
$ | 1.00 | | |
05/16/2023 | |
| 267,760 | | |
| - | | |
| (75 | ) | |
| (267,685 | ) | |
| - | |
ZNWAO | |
$ | 0.25 | | |
06/12/2023 | |
| 174,660 | | |
| - | | |
| - | | |
| (174,660 | ) | |
| - | |
ZNWAQ | |
$ | 0.05 | | |
12/31/2023 | |
| 23,428,348 | | |
| - | | |
| - | | |
| - | | |
| 23,428,348 | |
ZNWAV | |
$ | 0.05 | | |
06/28/2023 | |
| - | | |
| 288,500 | | |
| (167,730 | ) | |
| (120,770 | ) | |
| - | |
ZNWAW | |
$ | 0.05 | | |
07/13/2023 | |
| - | | |
| 199,000 | | |
| (151,500 | ) | |
| (47,500 | ) | |
| - | |
ZNWAX | |
$ | 0.05 | | |
07/31/2023 | |
| - | | |
| 818,500 | | |
| (458,750 | ) | |
| (359,750 | ) | |
| - | |
ZNWAY | |
$ | 0.05 | | |
09/10/2023 | |
| | | |
| 17,450 | | |
| (3,700 | ) | |
| (13,750 | ) | |
| - | |
ZNWAZ | |
$ | 0.25 | | |
07/17/2024 | |
| - | | |
| 153,500 | | |
| - | | |
| - | | |
| 153,500 | |
Outstanding warrants | |
| | | |
| |
| 35,234,137 | | |
| 1,476,950 | | |
| (790,905 | ) | |
| (5,677,562 | ) | |
| 30,242,620 | |
F.
Warrant Descriptions of Current Warrants
The
price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those
warrants with an expiration date beyond the balance sheet date.
|
|
|
|
Period of Grant |
|
US$ |
|
|
Expiration Date |
ZNWAA Warrants |
|
A,B,E |
|
March 2013 – December 2014 |
|
|
2.00 |
|
|
January 31, 2024 |
ZNWAG Warrants |
|
B,E |
|
October 2017 – December 2017 |
|
|
1.00 |
|
|
January 08, 2024 |
ZNWAJ Warrants |
|
A,B |
|
August 2018 – September 2018 |
|
|
1.00 |
|
|
October 29, 2023 |
ZNWAM Warrants |
|
C,F |
|
January 2021 – March 2021 |
|
|
0.05 |
|
|
December 31, 2023 |
ZNWAQ Warrants |
|
C,F |
|
June 2021 |
|
|
0.05 |
|
|
December 31, 2023 |
ZNWAS Warrants |
|
D |
|
August 2021 – March 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAT Warrants |
|
D |
|
August – September 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAU Warrants |
|
D |
|
October – November 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAZ Warrants |
|
G |
|
May – June 2023 |
|
|
.25 |
|
|
July 17, 2024 |
ZNWBA Warrants |
|
H |
|
November – December 2023 |
|
|
.25 |
|
|
January 15, 2025 |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
4 - Unproved Oil and Gas Properties, Full Cost Method
Unproved
oil and gas properties, under the full cost method, are comprised as follows:
| |
September 30, 2023 | | |
December 31, 2022 | |
| |
US$ thousands | | |
US$ thousands | |
Excluded from amortization base: | |
| | |
| |
Drilling costs, and other operational related costs | |
| 2,490 | | |
| 2,362 | |
Capitalized salary costs | |
| 2,419 | | |
| 2,342 | |
Capitalized interest costs | |
| 1,418 | | |
| 1,418 | |
Legal and seismic costs, license fees and other preparation costs | |
| 9,976 | | |
| 9,728 | |
Other costs | |
| 39 | | |
| 39 | |
| |
| 16,342 | | |
| 15,889 | |
Post
Impairment of unproved oil and gas properties are comprised as follows:
| |
For the three months ended September 30, | | |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Excluded from amortization base: | |
| | |
| | |
| | |
| |
Drilling costs, and other operational related costs | |
| 20 | | |
| - | | |
| 76 | | |
| - | |
Capitalized salary costs | |
| - | | |
| - | | |
| - | | |
| - | |
Capitalized interest costs | |
| - | | |
| - | | |
| - | | |
| - | |
Legal costs, license fees and other preparation costs | |
| 16 | | |
| - | | |
| 53 | | |
| - | |
Other costs | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| 36 | | |
| - | | |
| 129 | | |
| - | |
Changes
in Unproved oil and gas properties during the three and nine months ended September 30, 2023 and 2022 are as follows:
| |
For the three months ended September 30, | | |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
Excluded from amortization base: | |
| | |
| | |
| | |
| |
Drilling costs, and other operational related costs | |
| 58 | | |
| 5,350 | | |
| 204 | | |
| 10,666 | |
Capitalized salary costs | |
| 25 | | |
| 30 | | |
| 77 | | |
| 151 | |
Capitalized interest costs | |
| - | | |
| - | | |
| - | | |
| - | |
Legal costs, license fees and other preparation costs | |
| 103 | | |
| 586 | | |
| 301 | | |
| 1,402 | |
Other costs | |
| - | | |
| - | | |
| - | | |
| - | |
Impairment of unproved oil and gas properties | |
| (36 | ) | |
| - | | |
| (129 | ) | |
| - | |
| |
| *150 | | |
| *5,966 | | |
| *453 | | |
| *12,219 | |
Please
refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
5 - Right of use lease assets and lease obligations
The
Company is a lessee in several non-cancellable operating leases for transportation and office space.
The
table below presents the operating lease assets and liabilities recognized on the balance sheet as of September 30, 2023 and December
31, 2022:
| |
September 30, 2023 | | |
December 31, 2022 | |
| |
US$ thousands | | |
US$ thousands | |
Operating lease assets | |
$ | 246 | | |
$ | 202 | |
| |
| | | |
| | |
Operating lease liabilities: | |
| | | |
| | |
Current operating lease liabilities | |
$ | 192 | | |
$ | 196 | |
Non-current operating lease liabilities | |
$ | 53 | | |
$ | 12 | |
Total operating lease liabilities | |
$ | 245 | | |
$ | 208 | |
The
depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.
The
Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the
discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate
the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term
of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating
leases that commenced prior to that date.
The
Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of September 30, 2023
are:
| |
September 30, 2023 | |
Weighted average remaining lease term (years) | |
| 1.08 | |
Weighted average discount rate | |
| 5.9 | % |
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
5 - Right of use lease assets and leases obligations (cont’d)
The
table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable
operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets
as of September 30, 2023:
| |
US$ thousands | |
2023 | |
| 75 | |
2024 | |
| 178 | |
2025 | |
| - | |
2026 | |
| - | |
Thereafter | |
| - | |
Total undiscounted future minimum lease payments | |
| 253 | |
Less: portion representing imputed interest | |
| (8 | ) |
Total undiscounted future minimum lease payments | |
| 245 | |
* |
Less
than one thousand. |
Operating
lease costs were $76,000 and $203,000 for the three and nine months ended September 30, 2023, respectively. Operating lease costs are
included within general and administrative expenses on the statements of operations.
Operating
lease costs were $69,000 and $206,000 for the three and nine months ended September 30, 2022, respectively. Operating lease costs
are included within general and administrative expenses on the statements of operations.
Cash
paid for amounts included in the measurement of operating lease liabilities was $76,000 and $203,000 for the three and nine
months ended September 30, 2023, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $71,000
and $214,000 for the three and nine months ended September 30, 2022, respectively. These amounts are included in operating activities
in the statements of cash flows.
Right-of-use
assets obtained in exchange for new operating lease liabilities were $252,000 and $252,000 for the three and nine
months ended September 30, 2023, respectively.
Right-of-use
assets obtained in exchange for new operating lease liabilities were $nil and $136,000 for the three and nine months
ended September 30, 2022, respectively.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
6 - Commitments and Contingencies
A.
Securities and Exchange Commission (“SEC”) Investigation
As
previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting
a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation,
which we did.
On
April 5, 2023, the Company received from the Fort Worth Regional Office of the SEC written notice to the Company concluding the investigation
as to the Company and that the SEC does “not intend to recommend an enforcement action by the Commission against Zion.”
B.
Litigation
From
time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends
itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or
disputes.
The
Company is not subject to any litigation at the present time.
C. Market Conditions – Coronavirus
Pandemic and Israel-Hamas War
During March 2020, a global pandemic was declared
by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The
pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted
to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public
health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces
to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability
to work from home as needed.
See comments in “Subsequent Events” for the potential impact
of the Israel-Hamas War on our operations.
D.
Environmental and Onshore Licensing Regulatory Matters
The
Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental
clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and
gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner
and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous
Zion filings.
The
Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights
and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that
could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to
obtain all of the necessary authorizations and approvals to drill and production test exploration wells.
As
of September 30, 2023, and December 31, 2022, the Company accrued $nil and $nil for license regulatory matters.
E.
Bank Guarantees
As
of September 30, 2023, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $930,000)
and others (approximately $85,000) with respect to its drilling operation in an aggregate amount of approximately $1,015,000. The (cash)
funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance
sheets as fixed short-term bank deposits – restricted.
Zion
Oil & Gas, Inc.
Consolidated
Condensed Notes to Financial Statements (Unaudited)
Note
6 - Commitments and Contingencies (cont’d)
F.
Market Risk
Market
risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes
may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the
normal course of doing business, we are exposed to the market-related risks associated with foreign currency exchange rates and changes
in interest rates.
Foreign
Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated
in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with
the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2023 through September 30, 2023, the
USD has fluctuated by approximately 8.7% against the NIS (the USD strengthened relative to the NIS). Also, during the period January
1, 2022 through December 31, 2022, the USD fluctuated by approximately 13.2% against the NIS (the USD strengthened relative to the NIS).
Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date,
we have not hedged any of our currency exchange rate risks, but we may do so in the future.
Interest
Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank
deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term
nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities
of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of
our investment portfolio except for reduced income in a low interest rate environment. At September 30, 2023, we had cash, cash equivalents
and short-term bank deposits of approximately $1,530,000. The weighted average annual interest rate related to our cash and cash equivalents
for the three and nine months ended September 30, 2023, exclusive of funds at US banks that earn no interest, was approximately 4.45%
and 3.51%, respectively.
The
primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly
increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest
in high quality debt instruments.
Note
7 - Subsequent Events
| (i) | On
October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand
Israeli citizens. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date
of this report, Israel remains at war, which lead the Company to temporarily discontinue its exploration activities. It is currently
not determinable when the resumption of our exploration activities will begin. |
| (ii) | Approximately $391,000 was collected through the Company’s DSPP program during the period October 1 through November 7, 2023. |
| | |
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
THE FOLLOWING DISCUSSION SHOULD
BE READ IN CONJUNCTION WITH OUR UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND THE RELATED NOTES TO THOSE STATEMENTS
INCLUDED IN THIS FORM 10-Q. SOME OF OUR DISCUSSION IS FORWARD-LOOKING AND INVOLVES RISKS AND UNCERTAINTIES. FOR INFORMATION REGARDING
RISK FACTORS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS, REFER TO THE DISCUSSION OF RISK FACTORS IN THE “DESCRIPTION
OF BUSINESS” SECTION OF OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2022, FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION AND TO THE SUBSEQUENT EVENTS IN NOTE 7 OF THIS FORM 10-Q.
Forward-Looking
Statements
Certain
statements made in this discussion are “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements may materially differ from actual results.
Forward-looking
statements can be identified by terminology such as “may”, “should”, “expects”, “intends”,
“anticipates”, “believes”, “estimates”, “predicts”, or “continue” or the
negative of these terms or other comparable terminology and include, without limitation, statements regarding:
| ● | The Israel-Hamas war which began in October 2023 and its effect on our
exploration program; |
|
● |
the
going concern qualification in our consolidated financial statements; |
|
● |
our
ability to obtain new license areas to continue our petroleum exploration program; · |
|
● |
our
liquidity and our ability to raise capital to finance our overall exploration and development activities within our license area; |
|
● |
our
ability to continue meeting the requisite continued listing requirements by OTCQX; |
|
● |
business
interruptions from the COVID-19 pandemic and the Israel-Hamas war; |
| ● | interruptions, increased consolidated financial costs and
other adverse impacts of the coronavirus pandemic and the Israel-Hamas war on the drilling and testing of our petroleum exploration program and
our capital raising efforts; |
| ● | our
ability to explore for and develop natural gas and oil resources successfully and economically within a license area; |
|
● |
our
ability to maintain the exploration license rights to continue our petroleum exploration program; |
|
● |
the
availability of equipment, such as seismic equipment, drilling rigs, and production equipment as well as access to qualified personnel; |
|
● |
the
impact of governmental regulations, permitting and other legal requirements in Israel relating to onshore exploratory drilling; |
|
● |
our
estimates of the time frame within which future exploratory activities will be undertaken; |
|
● |
changes
in our exploration plans and related budgets; |
|
● |
the
quality of existing and future license areas with regard to, among other things, the existence of hydrocarbon reserves in economic
quantities; |
|
● |
anticipated
trends in our business; |
|
● |
our
future results of operations; |
|
● |
our
capital expenditure program; |
|
● |
future
market conditions in the oil and gas industry |
|
● |
the
demand for oil and natural gas, both locally in Israel and globally; and |
|
● |
the
impact of fluctuating oil and gas prices on our exploration efforts |
All
references in this Quarterly Report to the “Company”, “Zion”, “we”, “us”, or “our”,
are to Zion Oil and Gas, Inc., a Delaware corporation, and its wholly-owned subsidiaries, Zion Drilling, Inc. and Zion Drilling
Services, Inc. described below.
Current
Exploration and Operation Efforts
Zion
Oil and Gas, Inc., a Delaware corporation, is an oil and gas exploration company with a history of 23 years of oil and gas exploration
in Israel. We were incorporated in Florida on April 6, 2000 and reincorporated in Delaware on July 9, 2003. We completed our initial
public offering in January 2007. Our common stock, par value $0.01 per share (the “Common Stock”) currently trades on the
OTCQX marketplace of OTC Markets, Inc. under the symbol “ZNOG” and our Common Stock warrant under the symbol “ZNOGW.”
On January 24, 2020, the Company incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose
of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, the Company incorporated another wholly owned subsidiary,
Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When the Company is
not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling
services at market rates then in effect.
The
New Megiddo License 428 (“NML 428”) was initially awarded on December 3, 2020 for a six-month term and was extended several
times before expiring on February 1, 2023. Zion Oil & Gas, Inc. filed an amended application with the Israel Ministry of Energy for
a new exploratory license on January 24, 2023 covering the same area as its License No. 428, which expired on February 1, 2023. However,
its original application to replace License No. 428 was filed on May 11, 2022, and a revised application was filed on August 29, 2022.
On
September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434, allowing for oil and gas exploration on
approximately 75,000 acres or 302 square kilometers. This Exploration License 434 will be valid for three years until September 13, 2026
with four 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML
428.
We
continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum
system with significant exploration potential.
Zion
is deploying new technologies, focusing on new stimulation methods for MJ-01, and aiming to potentially unlock hydrocarbon flows in several
identified key zones. Zion has already procured service contractors and ancillary items required for efficient operations. Zion must
receive approval of its work plan from the Ministry of Energy prior to commencing its re-completion activities. Israel declared war on
Hamas in mid-October 2023 following the October 7, 2023 unprovoked attack on Israeli citizens by Hamas. Israel has formed an emergency
unity government in partial response to the attack. It is not known how long this war with Hamas will continue nor any specific timetable
for when Zion may resume its exploration activities.
The projected costs to perform the anticipated
re-completion activities for NMVL is expected to be $4,000,000 to $5,000,000 and require from three to six months.
I-35
Drilling Rig & Associated Equipment
| |
Nine-month period ended September 30, 2023 | |
| |
I-35 Drilling Rig | | |
Rig Spare Parts | | |
Other Drilling Assets | | |
Total | |
| |
US$ thousands | | |
US$ thousands | | |
US$ thousands | | |
US$ thousands | |
December 31, 2022 | |
| 5,225 | | |
| 619 | | |
| 437 | | |
| 6,281 | |
Asset Additions | |
| - | | |
| - | | |
| - | | |
| - | |
Asset Depreciation | |
| (476 | ) | |
| - | | |
| (94 | ) | |
| (570 | ) |
Asset Disposals for Self-Consumption | |
| - | | |
| (11 | ) | |
| - | | |
| (11 | ) |
September 30, 2023 | |
| 4,749 | | |
| 608 | | |
| 343 | | |
| 5,700 | |
Zion’s
ability to fully undertake all of these aforementioned activities is subject to its raising the needed capital from its continuing offerings,
of which no assurance can be provided, as well as the resumption of our activities following the war with Hamas.
Map
1. Zion’s Megiddo Valleys 434 License as of September 30, 2023.
Onshore
Licensing, Oil and Gas Exploration and Environmental Guidelines
The
Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental
cleanup of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas
wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner,
the Energy Ministry, and the Environmental Ministry in recent years as it pertains to oil and gas activities. Mention of these guidelines
was included in previous Zion Oil & Gas filings.
We
acknowledge that these new regulations are likely to increase the expenditures associated with obtaining new exploration rights and drilling
new wells. The Company expects that additional financial burdens could occur as a result of the Ministry requiring cash reserves that
could otherwise be used for operational purposes.
Capital
Resources Highlights
We
need to raise significant funds to finance the continued exploration efforts and maintain orderly operations. To date, we have funded
our operations through the issuance of our securities and convertible debt. We will need to continue to raise funds through the issuance
of equity and/or debt securities (or securities convertible into or exchangeable for equity securities). No assurance can be provided
that we will be successful in raising the needed capital on terms favorable to us (or at all).
The
Dividend Reinvestment and Stock Purchase Plan
On
March 13, 2014 Zion filed a registration statement on Form S-3 that is part of a replacement registration statement that was filed with
the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014.
On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration
No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The
Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed
and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and
replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.
On
March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders
and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly
from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original
Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration
Statement on Form S-3, as thereafter amended.
Please
see Footnote 3D (“Dividend Reinvestment and Stock Purchase Plan (“DSPP”)), which is a part of this Form 10-Q filing,
for details about specific stock purchase and unit programs, dates, and filings during the years 2016 through 2023.
For
the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program,
respectively. The $4,358,000 figure is net of $610,000 in equity issuance costs to an outside party.
For
the three and nine months ended September 30, 2022, approximately $3,477,000, and $16,740,000 were raised under the DSPP program,
respectively.
The
warrants balances at December 31, 2022 and transactions since January 1, 2023 are shown in the table below:
Warrants | |
Exercise Price | | |
Warrant Termination Date | |
Outstanding Balance, 12/31/2022 | | |
Warrants Issued | | |
Warrants Exercised | | |
Warrants Expired | | |
Outstanding Balance, 9/30/2023 | |
ZNWAA | |
$ | 2.00 | | |
01/31/2024 | |
| 1,498,804 | | |
| - | | |
| - | | |
| - | | |
| 1,498,804 | |
ZNWAD | |
$ | 1.00 | | |
05/02/2023 | |
| 243,853 | | |
| - | | |
| - | | |
| (243,853 | ) | |
| - | |
ZNWAE | |
$ | 1.00 | | |
05/01/2023 | |
| 2,144,099 | | |
| - | | |
| - | | |
| (2,144,099 | ) | |
| - | |
ZNWAF | |
$ | 1.00 | | |
08/14/2023 | |
| 359,435 | | |
| - | | |
| - | | |
| (359,435 | ) | |
| - | |
ZNWAG | |
$ | 1.00 | | |
01/08/2024 | |
| 240,068 | | |
| - | | |
| - | | |
| - | | |
| 240,068 | |
ZNWAH | |
$ | 5.00 | | |
04/19/2023 | |
| 372,400 | | |
| - | | |
| - | | |
| (372,400 | ) | |
| - | |
ZNWAI | |
$ | 3.00 | | |
06/29/2023 | |
| 640,710 | | |
| - | | |
| (100 | ) | |
| (640,610 | ) | |
| - | |
ZNWAJ | |
$ | 1.00 | | |
10/29/2023 | |
| 545,900 | | |
| - | | |
| - | | |
| - | | |
| 545,900 | |
ZNWAK | |
$ | 0.01 | | |
02/25/2023 | |
| 424,225 | | |
| - | | |
| (9,050 | ) | |
| (415,175 | ) | |
| - | |
ZNWAL | |
$ | 2.00 | | |
08/26/2023 | |
| 517,875 | | |
| - | | |
| - | | |
| (517,875 | ) | |
| - | |
ZNWAM | |
$ | 0.05 | | |
12/31/2023 | |
| 4,376,000 | | |
| - | | |
| - | | |
| - | | |
| 4,376,000 | |
ZNWAN | |
$ | 1.00 | | |
05/16/2023 | |
| 267,760 | | |
| - | | |
| (75 | ) | |
| (267,685 | ) | |
| - | |
ZNWAO | |
$ | 0.25 | | |
06/12/2023 | |
| 174,660 | | |
| - | | |
| - | | |
| (174,660 | ) | |
| - | |
ZNWAQ | |
$ | 0.05 | | |
12/31/2023 | |
| 23,428,348 | | |
| - | | |
| - | | |
| - | | |
| 23,428,348 | |
ZNWAV | |
$ | 0.05 | | |
06/28/2023 | |
| - | | |
| 288,500 | | |
| (167,730 | ) | |
| (120,770 | ) | |
| - | |
ZNWAW | |
$ | 0.05 | | |
07/13/2023 | |
| - | | |
| 199,000 | | |
| (151,500 | ) | |
| (47,500 | ) | |
| - | |
ZNWAX | |
$ | 0.05 | | |
07/31/2023 | |
| - | | |
| 818,500 | | |
| (458,750 | ) | |
| (359,750 | ) | |
| - | |
ZNWAY | |
$ | 0.05 | | |
09/10/2023 | |
| | | |
| 17,450 | | |
| (3,700 | ) | |
| (13,750 | ) | |
| - | |
ZNWAZ | |
$ | 0.25 | | |
07/17/2024 | |
| - | | |
| 153,500 | | |
| - | | |
| - | | |
| 153,500 | |
Outstanding warrants | |
| | | |
| |
| 35,234,137 | | |
| 1,476,950 | | |
| (790,905 | ) | |
| (5,677,562 | ) | |
| 30,242,620 | |
Principal
Components of our Cost Structure
Our
operating and other expenses primarily consist of the following:
|
● |
Impairment
of Unproved Oil and Gas Properties: Impairment expense is recognized if a determination is made that a well will not be commercially
productive. The amounts include amounts paid in respect of the drilling operations as well as geological and geophysical costs and
various amounts that were paid to Israeli regulatory authorities. |
|
● |
General
and Administrative Expenses: Overhead, including payroll and benefits for our corporate staff, costs of managing our exploratory
operations, audit and other professional fees, and legal compliance is included in general and administrative expenses. General and
administrative expenses also include non-cash stock-based compensation expense, investor relations related expenses, lease and insurance
and related expenses. |
|
● |
Depreciation,
Depletion, Amortization and Accretion: The systematic expensing of the capital costs incurred to explore for natural gas and oil
represents a principal component of our cost structure. As a full cost company, we capitalize all costs associated with our exploration,
and apportion these costs to each unit of production, if any, through depreciation, depletion and amortization expense. As we have
yet to have production, the costs of abandoned wells are written off immediately versus being included in this amortization pool. |
Going
Concern Basis
Since
we have limited capital resources, no revenue to date and a loss from operations, our consolidated financial statements have been prepared
on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business.
The appropriateness of using the going concern basis is dependent upon our ability to obtain additional financing or equity capital and,
ultimately, to achieve profitable operations. Therefore, there is substantial doubt about our ability to continue as a going concern
for one year from the date the financials were issued. The consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.
The
Impact of COVID-19
During March 2020, a global
pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”).
The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted
to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public
health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces
to work from home. As of the date of this report, the Company adopted a hybrid model whereby many of our employees are working from corporate
office two to three days per week and then working remotely two to three days per week.
The
full extent of COVID-19’s impact on our operations and financial performance depends on future developments that are uncertain
and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information
that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others.
The
main area in which Zion has experienced COVID-19’s impact has been in supply chain and/or logistics. We have worked with several
suppliers worldwide for the procurement of oil and gas parts, inventory items and related labor for our ongoing operations for the MJ-02
well. Production delays, factory shutdowns and heavy demand by oil and gas operators worldwide for spare parts has created some challenges
in obtaining these items in a timely fashion.
The Impact of the Israel-Hamas War
Please see Part II, Item 1a
for a discussion of the Israel-Hamas war and its effect on Zion’s exploration program.
Critical
Accounting Policies
Management’s
discussion and analysis of financial condition and results of operations is based upon our condensed consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation
of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and
the reported amounts of revenues and expense during the reporting period.
We
have identified the accounting principles which we believe are most critical to the reported financial status by considering accounting
policies that involve the most complex of subjective decisions or assessment.
Impairment
of Oil and Gas Properties
We
follow the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration
and development of oil and gas reserves, including directly related overhead costs, are capitalized.
All
capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production
method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until
proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that
the properties are impaired, the amount of the impairment is included in income from continuing operations before income taxes, and the
adjusted carrying amount of the unproved properties is amortized on the unit-of-production method.
Our
oil and gas properties represent an investment in unproved properties. These costs are excluded from the amortized cost pool until proved
reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine
if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. A further
impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other
information.
Abandonment
of properties is accounted for as adjustments to capitalized costs. The net capitalized costs are subject to a “ceiling test”
which limits such costs to the aggregate of the estimated present value of future net revenues from proved reserves discounted at ten
percent based on current economic and operating conditions, plus the lower of cost or fair market value of unproved properties. The recoverability
of amounts capitalized for oil and gas properties is dependent upon the identification of economically recoverable reserves, together
with obtaining the necessary financing to exploit such reserves and the achievement of profitable operations.
During
the three months ended September 30, 2023, and 2022, respectively, the Company recorded $36,000 and nil post-impairment charges.
During
the nine months ended September 30, 2023, and 2022, respectively, the Company recorded $129,000 and nil post-impairment charges.
The
total net book value of our unproved oil and gas properties under the full cost method is $16,342,000 and $15,889,000 at September 30,
2023 and at December 31, 2022, respectively.
Asset
Retirement Obligation
We
record a liability for asset retirement obligation at fair value in the period in which it is incurred and a corresponding increase in
the carrying amount of the related long-lived assets.
Fair
Value Considerations
We
follow ASC 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial
Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried
at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related
disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair
value measures. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in
an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most
advantageous market for that asset or liability.
There
are three levels of inputs to fair value measurements – Level 1, meaning the use of quoted prices for identical instruments in
active markets; Level 2, meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or
similar instruments in markets that are not active or are directly or indirectly observable; and Level 3, meaning the use of unobservable
inputs. We use Level 1 inputs for fair value measurements whenever there is an active market, with actual quotes, market prices, and
observable inputs on the measurement date. We use Level 2 inputs for fair value measurements whenever there are quoted prices for similar
securities in an active market or quoted prices for identical securities in an inactive market. We use observable market data whenever
available.
RESULTS
OF OPERATIONS
| |
For the three months ended September 30, | | |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
(US $ in thousands) | | |
(US $ in thousands) | |
Operating costs and expenses: | |
| | |
| | |
| | |
| |
General and administrative expenses | |
| 1,332 | | |
| 1,636 | | |
| 4,106 | | |
| 4,621 | |
Other | |
| 379 | | |
| 719 | | |
| 1,978 | | |
| 2,376 | |
Post impairment of unproved oil and gas properties | |
| 36 | | |
| - | | |
| 129 | | |
| - | |
Subtotal Operating costs and expenses | |
| 1,747 | | |
| 2,355 | | |
| 6,213 | | |
| 6,997 | |
| |
| | | |
| | | |
| | | |
| | |
Other expense (income), net | |
| (4 | ) | |
| 19 | | |
| 3 | | |
| 140 | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
| 1,743 | | |
| 2,374 | | |
| 6,216 | | |
| 7,137 | |
Revenue.
We currently have no revenue generating operations.
Operating
costs and expenses. Operating costs and expenses for the three and nine months ended September 30, 2023 were $1,747,000 and $6,213,000,
respectively, compared to $2,355,000 and $6,997,000, respectively, for the three and nine months ended September 30, 2022.
General
and administrative expenses. General and administrative expenses (“G&A expenses”) for the three and nine months ended
September 30, 2023 were $1,332,000 and $4,106,000, respectively, compared to $1,636,000 and $4,621,000, respectively, for the three and
nine months ended September 30, 2022. This expense grouping includes salaries, benefits, stock option expenses and professional fees.
G&A expenses decreased $304,000, or 19%, during the most recent quarter versus the prior year primarily due to lower expenses associated
with stock option grants. G&A expenses decreased $515,000, or 11%, primarily due to lower expenses associated with stock option grants.
Other
expense. Other expenses during the three and nine months ended September 30, 2023 were $379,000 and $1,978,000, respectively, compared
to $719,000 and $2,376,000, respectively, for the three and nine months ended September 30, 2022. Other general and administrative expenses
are comprised of non-compensation and non-professional expenses incurred. Other expenses decreased $340,000, or about 47%, for the three
months ended September 30, 2023 as a result of lower annual meeting expenses in 2023 and lower travel expenses. Other expenses for the
nine months ended September 30, 2023 decreased $398,000, or 17%, primarily due to lower annual meeting expenses.
Post
Impairment of unproved oil and gas properties. Post Impairment of unproved oil and gas properties expenses during the three
and nine months ended September 30, 2023 were $36,000 and $129,000 compared to nil and nil for the three and nine months ended September
30, 2022. The expenses recorded in 2023 are post impairment charges to the impairment recorded during 2022 related to the MJ-2 well.
Other
expense (income), net. Other expenses (income) during the three and nine months ended September 30, 2023 were ($4,000) and $3,000,
respectively, compared to $19,000 and $140,000, respectively, for the three and nine months ended September 30, 2022. The expenses in
this category are comprised of foreign currency exchange costs, primarily the New Israeli Shekel (NIS) to the US dollar, and financial
expenses/income. Overall, for the nine months ended September 30, 2022, total expenses in this category are $121,000 lower due to the
relative strengthening of the USD to the NIS during 2023.
Net Loss. Net loss
for the three and nine months ended September 30, 2023 was $1,743,000 and $6,216,000 compared to $2,374,000 and $7,137,000 for the three
and nine months ended September 30, 2022.
Liquidity
and Capital Resources
Liquidity
is a measure of a company’s ability to meet potential cash requirements. As discussed above, we have historically met our capital
requirements through the issuance of common stock as well as proceeds from the exercise of warrants and options to purchase common shares.
Our ability to continue as
a going concern is dependent upon obtaining the necessary financing to complete further exploration and development activities and generate
profitable operations from our oil and natural gas interests in the future. As we have expressed earlier in this Form 10-Q, our operations
are temporarily suspended due to the Israel-Hamas war. Although the war’s impact on our cash generation is not specifically known,
the Company has been able to generate needed capital under our DSPP since 2013 and through various equity private placements prior to
2013. The Company plans to continue issuing its common shares through the DSPP (see Footnote 3 for a new Unit program announced on November
6, 2023). Our current operations are dependent upon the adequacy of our current assets to meet our current expenditure requirements and
the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, our ability to
continue as a going concern will be impaired. Our financial statements for the nine months ended September 30, 2023 have been prepared
on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal
course of business. We have incurred a history of operating losses and negative cash flows from operations. Therefore, there
is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued.
At
September 30, 2023, we had approximately $510,000 in cash and cash equivalents compared to $1,735,000 at December 31, 2022, which does
not include any restricted funds. Our working capital (current assets minus current liabilities) was ($108,000) at September 30, 2023
and $661,000 at December 31, 2022.
As
of September 30, 2023, we provided bank guarantees to various governmental bodies (approximately $930,000) and others (approximately
$85,000) in respect of our drilling operation in the aggregate amount of approximately $1,015,000. The (cash) funds backing these guarantees
are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term
bank deposits restricted.
During
the nine months ended September 30, 2023, cash used in operating activities totaled $3,909,000. Cash provided by financing activities
during the nine months ended September 30, 2023 was $4,370,000 and is primarily attributable to proceeds received from the Dividend Reinvestment
and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as unproved oil
and gas properties, equipment and spare parts was $2,045,000 for the nine months ended September 30, 2023.
During
the nine months ended September 30, 2022, cash used in operating activities totaled $4,719,000. Cash provided by financing activities
during the nine months ended September 30, 2022 was $16,473,000 and is primarily attributable to proceeds received from the Dividend
Reinvestment and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as
unproved oil and gas properties, equipment and spare parts was $13,333,000 for the nine months ended September 30, 2022.
Accounting standards require management to evaluate our ability to
continue as a going concern for a period of one year subsequent to the date of the filing of this Form 10-Q. We expect to incur additional
significant expenditures to further our exploration and development programs. While we raised approximately $391,000 during the period
October 1, 2023 through November 7, 2023, we will need to raise additional funds in order to continue our exploration and development
activities in our license area. Additionally, we estimate that, when we are not actively drilling a well, our expenditures are approximately
$600,000 per month excluding exploratory operational activities. However, when we are actively drilling a well, we estimate an additional
minimum expenditure of approximately $2,500,000 per month. The above estimates are subject to change. Subject to the qualifications specified
below, management believes that our existing cash balance, excluding anticipated proceeds under the DSPP, will be sufficient to finance
our plan of operations through November 2023.
The outbreak of the coronavirus
and the Israel-Hamas war have to date significantly disrupted business operations. The extent to which the coronavirus and the war impacts
our operations, specifically our capital raising efforts, as well as our ability to continue our exploratory efforts, will depend on future
developments, which are highly uncertain and cannot be predicted with confidence.
No
assurance can be provided that we will be able to raise the needed operating capital.
Even
if we raise the needed funds, there are factors that can nevertheless adversely impact our ability to fund our operating needs, including
(without limitation), unexpected or unforeseen cost overruns in planned non-drilling exploratory work in existing license areas, the
costs associated with extended delays in undertaking the required exploratory work, and plugging and abandonment activities which is
typical of what we have experienced in the past.
The
financial information contained in these consolidated financial statements has been prepared on a basis that assumes that we will continue
as a going concern for one year from the date the financials were issued, which contemplates the realization of assets and the satisfaction
of liabilities and commitments in the normal course of business. This financial information and these condensed consolidated financial
statements do not include any adjustments that may result from the outcome of this uncertainty.
Off-Balance
Sheet Arrangements
We
do not currently use any off-balance sheet arrangements to enhance our liquidity or capital resource position, or for any other purpose.
Recently
Issued Accounting Pronouncements
The
Company does not believe that the adoption of any recently issued accounting pronouncements in 2023 had a significant impact on our financial
position, results of operations, or cash flow.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market
risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes
may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the
normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest
rates.
Foreign
Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated
in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with
the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2023 through September 30, 2023, the
USD has fluctuated by approximately 8.7% against the NIS (the USD strengthened relative to the NIS). Also, during the period January
1, 2022 through December 31, 2022, the USD fluctuated by approximately 13.2% against the NIS (the USD strengthened relative to the NIS).
Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date,
we have not hedged any of our currency exchange rate risks, but we may do so in the future.
Interest
Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits
and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject
to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments,
we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio
except for reduced income in a low interest rate environment. At September 30, 2023 we had cash, cash equivalents and short-term and
long-term bank deposits, including restricted Israeli deposits, of approximately $1,530,000. The weighted average annual interest rate
related to our cash and cash equivalents for the three and nine months ended September 30, 2023, exclusive of funds at US banks that
earn no interest, was approximately 4.45% and 3.51%, respectively.
The
primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly
increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest
in high quality debt instruments.
ITEM
4. CONTROLS AND PROCEDURES
We
maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that we file
or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time period specified
in the SEC’s rules and forms. As of September 30, 2023, our chief executive officer and our chief financial officer conducted an
evaluation of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and
our chief financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2023.
Changes
in Internal Control over Financial Reporting
There
were no changes in internal controls over financial reporting that occurred during the quarter ended September 30, 2023 that have materially
affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
PART
II—OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
Securities
and Exchange Commission (“SEC”) Investigation
As
previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting
a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation,
which we did.
On
April 5, 2023, the Company received from the Fort Worth Regional Office of the SEC written notice to the Company concluding the investigation
as to the Company and that the SEC does “not intend to recommend an enforcement action by the Commission against Zion.”
Litigation
From
time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends
itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or
disputes.
The
Company is not subject to any litigation at the present time.
ITEM
1A. RISK FACTORS
During the quarter ended September
30, 2023, there were no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended
December 31, 2022. However, as described in Footnote 7 – Subsequent Events, the Gaza militant terrorist organization Hamas infiltrated
southern Israel on October 7, 2023, and Israel subsequently declared war on Hamas. We are, therefore, adding an additional risk factor
as follows:
Our
exploration focus on the nation of Israel subjects us to operational risks associated with various uncertainties associated with wars
and skirmishes between Israel and other organizations and/or countries, including , but not limited to, Hamas, Hezbollah, Palestinian
Islamic Jihad and Iran.
Our operation requires us
to bring certain equipment, supplies and personnel into Israel and we also require the cooperation and approval of several departments,
agencies and ministries within Israel. When Israel is at war and all of Israel’s national focus is on accomplishing its wartime
objectives, our ability to pursue our exploration program is adversely affected. We, therefore, have no way to determine how long Israel
will remain at war and the resulting impacts on our business.
ITEM
2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS
None.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
None.
ITEM
5. OTHER INFORMATION:
None.
ITEM
6. EXHIBITS
Exhibit
Index:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
ZION
OIL & GAS, INC. |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/
Robert W.A. Dunn |
|
By: |
/s/
Michael B. Croswell Jr. |
|
Robert
W. A. Dunn |
|
|
Michael
B. Croswell Jr. |
|
Chief
Executive Officer |
|
|
Chief
Financial Officer |
|
(Principal
Executive Officer) |
|
|
(Principal
Financial and Accounting Officer) |
|
|
|
|
|
Date: |
November
9, 2023 |
|
Date: |
November
9, 2023 |
46
NONE
3
11
10
20
454890000
484678000
551551000
578497000
1.00
50
false
--12-31
Q3
0001131312
0001131312
2023-01-01
2023-09-30
0001131312
2023-11-07
0001131312
2023-09-30
0001131312
2022-12-31
0001131312
2023-07-01
2023-09-30
0001131312
2022-07-01
2022-09-30
0001131312
2022-01-01
2022-09-30
0001131312
us-gaap:CommonStockMember
2022-12-31
0001131312
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001131312
us-gaap:RetainedEarningsMember
2022-12-31
0001131312
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-09-30
0001131312
us-gaap:RetainedEarningsMember
2023-01-01
2023-09-30
0001131312
us-gaap:CommonStockMember
2023-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001131312
us-gaap:RetainedEarningsMember
2023-09-30
0001131312
us-gaap:CommonStockMember
2023-06-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001131312
us-gaap:RetainedEarningsMember
2023-06-30
0001131312
2023-06-30
0001131312
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001131312
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001131312
us-gaap:CommonStockMember
2021-12-31
0001131312
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001131312
us-gaap:RetainedEarningsMember
2021-12-31
0001131312
2021-12-31
0001131312
us-gaap:CommonStockMember
2022-01-01
2022-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-09-30
0001131312
us-gaap:RetainedEarningsMember
2022-01-01
2022-09-30
0001131312
us-gaap:CommonStockMember
2022-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001131312
us-gaap:RetainedEarningsMember
2022-09-30
0001131312
2022-09-30
0001131312
us-gaap:CommonStockMember
2022-06-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001131312
us-gaap:RetainedEarningsMember
2022-06-30
0001131312
2022-06-30
0001131312
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001131312
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001131312
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001131312
2022-01-01
2022-12-31
0001131312
zn:I35DrillingRigMember
2022-12-31
0001131312
zn:RigSparePartsMember
2022-12-31
0001131312
zn:OtherDrillingAssetsMember
2022-12-31
0001131312
zn:I35DrillingRigMember
2023-01-01
2023-09-30
0001131312
zn:RigSparePartsMember
2023-01-01
2023-09-30
0001131312
zn:OtherDrillingAssetsMember
2023-01-01
2023-09-30
0001131312
zn:I35DrillingRigMember
2023-09-30
0001131312
zn:RigSparePartsMember
2023-09-30
0001131312
zn:OtherDrillingAssetsMember
2023-09-30
0001131312
us-gaap:CommonStockMember
2023-06-07
0001131312
srt:MinimumMember
zn:AmendedAndRestatedCertificateOfIncorporationMember
2023-06-07
0001131312
srt:MaximumMember
zn:AmendedAndRestatedCertificateOfIncorporationMember
2023-06-07
0001131312
zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember
2021-06-01
2021-06-09
0001131312
zn:FiveSeniorOfficersAndOneStaffMember
2023-01-01
2023-09-30
0001131312
zn:FiveSeniorOfficersAndOneStaffMember
2023-09-30
0001131312
zn:OneSeniorOfficersMember
2023-01-01
2023-09-30
0001131312
zn:OneSeniorOfficersMember
2023-09-30
0001131312
zn:OneBoardMember
2023-01-01
2023-09-30
0001131312
zn:OneBoardMember
2023-09-30
0001131312
zn:OneBoardMember
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2023-01-01
2023-09-30
0001131312
zn:OneStaffMember
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2023-01-01
2023-09-30
0001131312
zn:OneStaffMember
2023-09-30
0001131312
zn:FiveStaffMembersAndOneSeniorOfficerMember
2023-01-01
2023-09-30
0001131312
zn:FiveStaffMembersAndOneSeniorOfficerMember
2023-09-30
0001131312
zn:FourSeniorOfficersAndNineStaffMember
2023-01-01
2023-09-30
0001131312
zn:FourSeniorOfficersAndNineStaffMember
2023-09-30
0001131312
srt:ScenarioForecastMember
zn:FourSeniorOfficersAndNineStaffMember
2024-01-01
2024-09-30
0001131312
zn:NineBoardMember
2023-01-01
2023-09-30
0001131312
zn:NineBoardMember
2023-09-30
0001131312
srt:ScenarioForecastMember
zn:NineBoardMember
2024-01-01
2024-09-30
0001131312
zn:ThreeConsultantsMember
2023-01-01
2023-09-30
0001131312
zn:ThreeConsultantsMember
2023-09-30
0001131312
srt:ScenarioForecastMember
zn:ThreeConsultantsMember
2024-01-01
2024-09-30
0001131312
zn:SixSeniorOfficersAndOneStaffMember
2022-01-01
2022-09-30
0001131312
zn:SixSeniorOfficersAndOneStaffMember
2022-09-30
0001131312
zn:SixSeniorOfficersAndOneStaffMember
2023-01-01
2023-09-30
0001131312
zn:OneSeniorOfficersMember
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:OneSeniorOfficersMember
2022-09-30
0001131312
zn:OneSeniorOfficersMember
2022-01-01
2022-09-30
0001131312
zn:oneSeniorOfficerAndOneStaffMember
2022-01-01
2022-09-30
0001131312
zn:oneSeniorOfficerAndOneStaffMember
2022-09-30
0001131312
zn:oneSeniorOfficerAndOneStaffMember
2023-01-01
2023-09-30
0001131312
zn:OneBoardMember
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2022-09-30
0001131312
zn:OneBoardMember
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:FiveSeniorOfficersAndFourStaffMember
2023-01-01
2023-09-30
0001131312
zn:FiveSeniorOfficersAndFourStaffMember
2022-09-30
0001131312
zn:FiveSeniorOfficersAndFourStaffMember
2022-01-01
2022-09-30
0001131312
zn:SevenBoardMember
2022-01-01
2022-09-30
0001131312
zn:SevenBoardMember
2022-09-30
0001131312
zn:SevenBoardMember
2023-01-01
2023-09-30
0001131312
zn:FourStaffMember
2022-01-01
2022-09-30
0001131312
zn:FourStaffMember
2022-09-30
0001131312
zn:FourStaffMember
2023-01-01
2023-09-30
0001131312
zn:SixStaffMember
2023-01-01
2023-09-30
0001131312
zn:SixStaffMember
2022-09-30
0001131312
zn:SixStaffMember
2022-01-01
2022-09-30
0001131312
zn:TwoConsultantsMember
2023-01-01
2023-09-30
0001131312
zn:TwoConsultantsMember
2022-09-30
0001131312
zn:TwoConsultantsMember
2022-01-01
2022-09-30
0001131312
zn:OneBoardMember
2022-01-01
2022-09-30
0001131312
zn:OneBoardMember
2022-09-30
0001131312
zn:FiveSeniorOfficersTwoConsultantsMember
2023-01-01
2023-09-30
0001131312
zn:FiveSeniorOfficersTwoConsultantsMember
2022-09-30
0001131312
zn:FiveSeniorOfficersTwoConsultantsMember
2022-01-01
2022-09-30
0001131312
zn:OneSeniorOfficerOneBoardMember
2022-01-01
2022-09-30
0001131312
zn:OneSeniorOfficerOneBoardMember
2022-09-30
0001131312
zn:OneSeniorOfficerOneBoardMember
2023-01-01
2023-09-30
0001131312
zn:EightBoardMember
2023-01-01
2023-09-30
0001131312
zn:EightBoardMember
2022-09-30
0001131312
zn:EightBoardMember
2022-01-01
2022-09-30
0001131312
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2022-01-01
2022-09-30
0001131312
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2022-09-30
0001131312
zn:TwoZeroTwoOneEquityOmnibusPlanMember
2023-01-01
2023-09-30
0001131312
zn:TwoSeniorOfficersAndFourStaffMember
2023-01-01
2023-09-30
0001131312
zn:TwoSeniorOfficersAndFourStaffMember
2022-09-30
0001131312
zn:FourStaffMembersAndOneConsultantMember
2023-01-01
2023-09-30
0001131312
zn:FourStaffMembersAndOneConsultantMember
2022-09-30
0001131312
zn:OneStaffMember
2023-01-01
2023-09-30
0001131312
zn:OneStaffMember
2022-09-30
0001131312
zn:FourSeniorOfficersAndThirteenStaffMember
2023-01-01
2023-09-30
0001131312
zn:FourSeniorOfficersAndThirteenStaffMember
2022-09-30
0001131312
zn:FourSeniorOfficersAndThirteenStaffMember
2022-01-01
2022-09-30
0001131312
zn:NineBoardMember
2022-01-01
2022-09-30
0001131312
zn:NineBoardMember
2022-09-30
0001131312
zn:NineBoardMember
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:OneSeniorOfficerOneBoardMemberAndFourStaffMember
2022-01-01
2022-09-30
0001131312
zn:OneSeniorOfficerOneBoardMemberAndFourStaffMember
2022-09-30
0001131312
zn:OneSeniorOfficerOneBoardMemberAndFourStaffMember
2023-01-01
2023-09-30
0001131312
us-gaap:WarrantMember
2015-01-13
0001131312
us-gaap:CommonStockMember
2015-01-13
0001131312
2018-05-02
0001131312
2016-11-01
0001131312
2020-05-01
2020-05-01
0001131312
zn:ZNWAEWarrantsMember
2019-05-29
0001131312
zn:ZNWAEWarrantsMember
2020-09-15
0001131312
2017-05-22
0001131312
zn:NewUnitProgramMember
zn:ZnwafMember
2020-08-14
2020-08-14
0001131312
us-gaap:CommonStockMember
2023-09-30
0001131312
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAGMember
2023-01-01
2023-09-30
0001131312
us-gaap:WarrantMember
2018-01-08
2023-01-08
0001131312
us-gaap:WarrantMember
2023-01-08
0001131312
2018-02-01
0001131312
us-gaap:CommonStockMember
2018-02-01
2018-02-01
0001131312
zn:ZNHAHMember
2018-02-01
2018-02-01
0001131312
2020-04-02
2020-04-02
0001131312
us-gaap:WarrantMember
2018-12-04
0001131312
zn:ZNWAHMember
2019-05-29
0001131312
zn:ZNWAHMember
2020-09-15
0001131312
2018-08-21
0001131312
2018-08-21
2018-08-21
0001131312
2020-10-29
2020-10-29
0001131312
2020-10-29
0001131312
zn:ZnwajWarrantsMember
2019-05-29
0001131312
zn:ZnwajWarrantsMember
2020-09-15
0001131312
2018-12-10
0001131312
zn:FiveSeniorOfficersMember
2018-12-10
0001131312
us-gaap:WarrantMember
2018-12-10
0001131312
2020-02-25
2020-02-25
0001131312
zn:ZNWALMember
2023-01-01
2023-09-30
0001131312
zn:ZNWALMember
2023-09-30
0001131312
2021-08-26
2021-08-26
0001131312
zn:ZNWAMWarrantMember
2022-03-21
0001131312
2022-03-21
0001131312
zn:ZnwanWarrantMember
2023-09-30
0001131312
2021-05-16
0001131312
zn:ZnwanWarrantMember
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAOMember
2023-09-30
0001131312
us-gaap:WarrantMember
2021-06-12
2023-06-12
0001131312
us-gaap:WarrantMember
2022-05-05
2023-05-05
0001131312
srt:ScenarioForecastMember
us-gaap:WarrantMember
2025-11-15
2025-12-31
0001131312
zn:ZNWAUWarrantsMember
2023-09-30
0001131312
srt:ScenarioForecastMember
2025-11-15
2025-12-31
0001131312
zn:ZionMember
2023-01-01
2023-09-30
0001131312
srt:MinimumMember
zn:ZionMember
2023-01-01
2023-09-30
0001131312
srt:MaximumMember
2023-01-01
2023-09-30
0001131312
zn:OTCQXWarrantsMember
2023-01-01
2023-09-30
0001131312
zn:OTCQXWarrantsMember
2023-09-30
0001131312
zn:ZNWAVWarrantsMember
2023-09-30
0001131312
zn:ZNWAYMember
2023-09-30
0001131312
zn:ZNWAVWarrantsMember
2023-06-28
0001131312
zn:ZNWAWWarrantsMember
2023-07-13
0001131312
zn:ZNWAXWarrantsMember
2023-07-31
0001131312
zn:ZNWAYMember
2023-09-10
0001131312
us-gaap:WarrantMember
2023-01-01
2023-09-30
0001131312
us-gaap:WarrantMember
us-gaap:CommonStockMember
2023-01-01
2023-09-30
0001131312
zn:OTCQXWarrantsMember
us-gaap:CommonStockMember
2023-09-30
0001131312
us-gaap:WarrantMember
us-gaap:CommonStockMember
2023-09-30
0001131312
zn:ZNWAZWarrantsMember
2023-09-30
0001131312
srt:ScenarioForecastMember
zn:ZNWAZWarrantsMember
2024-07-17
0001131312
zn:ZNWBAWarrantMember
2023-09-30
0001131312
us-gaap:WarrantMember
2023-09-30
0001131312
us-gaap:SubsequentEventMember
2023-10-01
2023-11-07
0001131312
us-gaap:WarrantMember
2019-05-29
0001131312
us-gaap:WarrantMember
2020-09-15
0001131312
us-gaap:WarrantMember
2022-03-21
0001131312
us-gaap:WarrantMember
2022-12-14
0001131312
us-gaap:WarrantMember
2022-12-28
0001131312
us-gaap:EmployeeStockMember
2022-12-31
0001131312
us-gaap:EmployeeStockMember
2023-01-01
2023-09-30
0001131312
us-gaap:EmployeeStockMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesOneMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesOneMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesOneMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesOneMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwoMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwoMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwoMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwoMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThreeMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThreeMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThreeMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThreeMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSixMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSixMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesSixMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesSixMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSevenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesSevenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesSevenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesEightMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesEightMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesEightMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesEightMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesNineMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesNineMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesNineMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesNineMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesElevenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesElevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesElevenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesElevenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwelveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwelveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwelveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwelveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFifteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFifteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFifteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFifteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSixteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSixteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesSixteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesSixteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSeventeenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesSeventeenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesSeventeenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesSeventeenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesEighteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesEighteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesEighteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesEighteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesNineteenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesNineteenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesNineteenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesNineteenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyOneMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyOneMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyOneMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyOneMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyTwoMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyTwoMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyTwoMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyTwoMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyThreeMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyThreeMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyThreeMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyThreeMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyFourMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyFourMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyFourMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyFourMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyFiveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentyFiveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyFiveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyFiveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentySixMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentySixMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentySixMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentySixMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentySevenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesTwentySevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentySevenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentySevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyEightMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyEightMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyNineMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesTwentyNineMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyOneMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyOneMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyOneMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyOneMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyTwoMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyTwoMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyTwoMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyTwoMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyThreeMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyThreeMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyThreeMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyThreeMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyFourMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyFourMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyFourMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyFourMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyFiveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyFiveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyFiveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyFiveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtySixMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtySixMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtySixMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtySixMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtySevenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtySevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtySevenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtySevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyEightMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyEightMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyNineMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesThirtyNineMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyNineMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesThirtyNineMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangeFourtyOneMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangeFourtyOneMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangeFourtyOneMember
2023-09-30
0001131312
zn:VestedMember
zn:RangeFourtyOneMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyTwoMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyTwoMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyTwoMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyTwoMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyThreeMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyThreeMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyThreeMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyThreeMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyFourMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyFourMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyFourMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyFourMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyFiveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyFiveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyFiveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyFiveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtySixMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtySixMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtySixMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtySixMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtySevenMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtySevenMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtySevenMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtySevenMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyEightMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyEightMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyEightMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyEightMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyNineMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFourtyNineMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyNineMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFourtyNineMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyOneMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyOneMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyOneMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyOneMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyTwoMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyTwoMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyTwoMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyTwoMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyThreeMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyThreeMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyThreeMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyThreeMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyFourMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyFourMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyFourMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyFourMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyFiveMember
2023-09-30
0001131312
zn:NonvestedMember
zn:RangesFiftyFiveMember
2023-01-01
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyFiveMember
2023-09-30
0001131312
zn:VestedMember
zn:RangesFiftyFiveMember
2023-01-01
2023-09-30
0001131312
zn:NonvestedMember
2023-09-30
0001131312
zn:NonvestedMember
2023-01-01
2023-09-30
0001131312
srt:MinimumMember
zn:VestedMember
2023-09-30
0001131312
srt:MaximumMember
zn:VestedMember
2023-09-30
0001131312
zn:VestedMember
2023-09-30
0001131312
zn:VestedMember
2023-01-01
2023-09-30
0001131312
zn:EmployeesMember
2023-01-01
2023-09-30
0001131312
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2023-01-01
2023-09-30
0001131312
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2022-01-01
2022-09-30
0001131312
srt:MinimumMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2023-01-01
2023-09-30
0001131312
srt:MaximumMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2023-01-01
2023-09-30
0001131312
srt:MinimumMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2022-01-01
2022-09-30
0001131312
srt:MaximumMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
2022-01-01
2022-09-30
0001131312
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2023-01-01
2023-09-30
0001131312
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2022-01-01
2022-09-30
0001131312
srt:MinimumMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2022-01-01
2022-09-30
0001131312
srt:MaximumMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2022-01-01
2022-09-30
0001131312
zn:EmployeesAndDirectorsMember
2023-07-01
2023-09-30
0001131312
zn:EmployeesAndDirectorsMember
2022-07-01
2022-09-30
0001131312
zn:EmployeesAndDirectorsMember
2023-01-01
2023-09-30
0001131312
zn:EmployeesAndDirectorsMember
2022-01-01
2022-09-30
0001131312
zn:NonemployeesMember
2023-07-01
2023-09-30
0001131312
zn:NonemployeesMember
2022-07-01
2022-09-30
0001131312
zn:NonemployeesMember
2023-01-01
2023-09-30
0001131312
zn:NonemployeesMember
2022-01-01
2022-09-30
0001131312
zn:NonEmployeesAndCapitalizedUnprovedOilGasPropertiesMember
2023-07-01
2023-09-30
0001131312
zn:NonEmployeesAndCapitalizedUnprovedOilGasPropertiesMember
2022-07-01
2022-09-30
0001131312
zn:NonEmployeesAndCapitalizedUnprovedOilGasPropertiesMember
2023-01-01
2023-09-30
0001131312
zn:NonEmployeesAndCapitalizedUnprovedOilGasPropertiesMember
2022-01-01
2022-09-30
0001131312
zn:DividendReinvestmentAndStockPurchasePlanMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaaWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwaaWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwaaWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaaWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwadWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwadWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwadWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwadWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwaeWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwaeWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwaeWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaeWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwafMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwafMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwafMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwafMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwagMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwagMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwagMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwagMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwahMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwahMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwahMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwahMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwaiWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwaiWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwaiWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaiWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwajWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwajWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwajWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwajWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwakWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwakWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwakWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwakWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwalWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwalWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwalWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwalWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwamWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwamWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwamWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwamWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwanWarrantMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwanWarrantMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwanWarrantMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwanWarrantMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwaoWarrantMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZnwaoWarrantMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZnwaoWarrantMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaoWarrantMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAQWarrantMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAQWarrantMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAQWarrantMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAQWarrantMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAVWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAVWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAVWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAVWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAWWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAWWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAWWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAWWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAXWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAXWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAXWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAXWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAYWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAYWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAYWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAYWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZNWAZWarrantsMember
zn:WarrantTransactionsMember
2022-12-31
0001131312
zn:ZNWAZWarrantsMember
zn:WarrantTransactionsMember
2022-01-01
2022-12-31
0001131312
zn:ZNWAZWarrantsMember
zn:WarrantTransactionsMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAZWarrantsMember
zn:WarrantTransactionsMember
2023-09-30
0001131312
zn:ZnwaaWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZnwaaWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZNWAGWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAGWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZnwajWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZnwajWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZnwamWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZnwamWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZNWAQWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAQWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZnwasWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZnwasWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZnwatWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZnwatWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZNWAUWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAUWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZNWAZWarrantsMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZNWAZWarrantsMember
us-gaap:InvestorMember
2023-09-30
0001131312
zn:ZNWBAWarrantMember
us-gaap:InvestorMember
2023-01-01
2023-09-30
0001131312
zn:ZNWBAWarrantMember
us-gaap:InvestorMember
2023-09-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
iso4217:USD
compsci:item
xbrli:pure
License No. 434 “Megiddo Valleys”
This LICENSE is granted to Zion Oil & Gas Inc. (100%)
This LICENSE is granted over the area described in the
First Annex.
This LICENSE is granted – subject to the provisions
of the Petroleum Law, 5712-1952, and the regulations issued pursuant thereto, and to the special conditions detailed in the Second Annex,
which is an integral part of this license.
License No. 434 “New Megiddo”
This license is granted for the period of 14 September
2023 until 13 September 2026.
During the license period the Licensee shall carry out
the work program as follows:
1.2 For the avoidance
of doubt, “Licensee” means any of the licensees listed above, jointly and severally, including their substitutes approved by
law. The obligations imposed on the licensee in the license will apply to each of the license recipients, or their said substitutes.
2.1 The license
period is the period of 3 years as specified in the second appendix to this license, (respectively “The Second Addendum”, “The
Original Period).
2.2 The license
period can be extended for additional periods subject to the compliance of provisions of the law, regulations and all the following conditions:
2.2.1 The
licensee shall carry out with due diligence in the Original Period the work plan set forth in the Second Schedule in accordance with the
schedule in the Second Schedule, or as extended by the approval of the Commissioner.
2.2.2 The licensee
drilled one exploratory well and undertook a work plan which will be approved by the Commissioner.
2.2.3 Application
for extension of the license period for the additional period after the end of the Original Period if the Licensee has not had a discovery
in the area of the license, shall be submitted at least one month prior to the end of the Original Period, and will include the details
required by the Law and Petroleum Regulations, including details regarding the technical and financial capacity of the licensee to meet
the proposed work plan.
2.3 Notwithstanding the provisions of
section 2.2 of this license, if the licensee has a discovery in the area of the license, the license period may be extended for a period
of up to two years, in accordance with the provisions of section 18 (b) (2) of the Law.
3.1
The owner of a license has the following rights, subject to provisions of the law:
3.2
The right to explore for oil in the drilling license area.
3.3 In the event
and pursuant to conditions set by the Commissioner, the right to carry on exploration activities outside of the license area that can
assist in evaluating oil potential in the license area.
3.4 Sole right
to drill exploration and development drilling in the license area and produce oil from said wells.
3.5
The right to receive a lease after discovery in the license area.
4. Obligations of License Owner:
Applicability of laws
4.1 The license
owner shall act with due diligence with regard to exploration activities within the potential oil resource within the license area with
initiative and efficiency, pursuant to the license and accepted professional course of action.
4.2 In performance
of activities regarding the license, the license owner shall act in accordance with:
4.2.1 Provisions
of the law, the law and regulations including Petroleum Regulations, Regulations to deviate from Planning and Building law and Petroleum
Commissioner Guidelines.
4.2.2 Labor safety
legislation, protection of environment legislation, hazardous material legislation, Gas Law, Natural gas economy law(safety and license)1989
and any other relevant law as legislated from time to time that apply to the license owner or relate to the license or activities performed
in connection with the license.
4.2.3 The Minister’s
orders pursuant to their authority by law, and the instructions of the Commissioner pursuant to lawful authority or the contents of the
license, including terms and instructions set by confirmation documents, as well as requirements and instructions by and authorized party
pursuant to any law.
4.3 The license
owner shall take action to obtain any agreement or permit required from any government person pursuant to any law.
4.4 During the
duration of this license the license holder shall meet all professional financial requirements as set forth in Commissioners guidelines
for application for onshore exploration licenses.
5.1 The work program
in the second addendum, as amended from time to time (hereinafter “the work program”) is an integral part of the license.
5.2 The license
owner shall perform the work program with due diligence in accordance with good oilfield practice. Good oilfield practice shall be deemed
the practice, methods, procedures that are common by operators with expertise and experience in the oil and gas sector, operating with
caution, and at the relevant time , using reasonable discretion and taking into consideration the facts at the time that the decision
was made, will be those expected to achieve the desired results and goals.
6.1 A well shall
be drilled after receiving permission beforehand from the Commissioner. And any other permit from any other authority required to drill,
including permits from the planning authority. The Commissioner is permitted not to approve to drill a well in the event that the Commissioner
is of the opinion that there are circumstances that justify this including regarding the the place where the well will be drilled, effect
on the surroundings etc..
6.2 Where
the owner of the license undertakes to drill an exploration well, the said license owner shall drill and aim to the target set in the
work program, or the target that has been approved by the Commissioner prior to the drilling.
6.3 The owner
of the license shall request from the Commissioner permission for any spud or reentry to drill, and plug, or abandonment of a well.
6.4
The request shall include details and data as the Commissioner shall decide.
6.5
The Commissioner may permit the drilling subject to the conditions.
6.6 Any temporary
or permanent plug or abandonment of the well, shall be performed according to the demands of the Commissioner, and in such a manner that
the well is in good condition and allow continual work on the well.
6.7 Prior to the
expiry of the license the license owner hall pug and abandon any well that has been drilled, or that has been reentered per the license
and which has not yet been plugged and abandoned , pursuant to good oilfield practice and in accordance with the requirements and guidelines
of the Commissioner, unless agreed otherwise by the Commissioner.
7.1 The license
owner shall immediately notify the Commissioner of any discovery when they have learned of such, pursuant to the Petroleum law and regulations.
7.2 The notice
shall include details and information as specified inb the Commissioner guidelines to approve a discovery.
7.3 If the Commissioner
shall approve that the license owner has made a discovery, and the license owner has submitted during the license period a request to
receive a lease according to the law and regulations, the license owner shall be entitled, subject to the terms herein, the law and regulations,
and subject to any other law that applies to the license owner, to receive from the Commissioner a lease deed relating to the area which
shall not exceed 250 square kilometers including the license area and the area of the discovery.
7.4 The
lease deed shall include additional terms from those included in the license, regarding granting the lease including development and commercial
production of the oil.
7.5 Upon issuance
of the lease deed the license shall expire, and the rights that are not included in the lease shall return to the State.
7.6 In the event that the license
owner shall have a discovery in the license area, then license owner is obligated , unless there is a reason to contradict this
obligation, to produce oil, to set the boundaries of the oil field and develop it-with due diligence – as if he was holder
of the lease and license owner is bound by the same obligations of a lease holder regarding those actions and the oil that is
produced and this term shall not derogate from the obligations as a license owner.
8.1 The license
owner shall keep samples pursuant to the Petroleum Law, the Petroleum Regulations and Commissioner Guidelines.
8.2 The license
owner shall submit to the Commissioner records, reports pursuant to the law, regulations, the terms of the license and Commissioner guidelines.
8.3 the license
owner shall submit to the Commissioner an immediate report regarding any substantive exceptional event, including an event whereby injury
has been caused or any be caused to any person, property or the environment.
8.4 The license
owner shall submit to the Commissioner reports according to the law, regulations and the Commissioner guidelines, any information that
license owner has in their possession any agreement, report or any other document that is required according to the Commissioner for supervision
over the license owner and their activities regarding the license.
8.5 All information
that shall be submitted to the Commissioner shall be held by the Commissioner and shall be treated according to the law, regulations,
and the guidelines of the commissioner. The commissioner shall be entitled to make use of the data and the information as the Commissioner
sees fit, for the best development of oil resource in Israel. It is hereby emphasized that upon expiry of the right the State is entitled
to publicize all the information regarding the area of the right including furnishing to one who requests in consideration for payments
set by the State.
8.6 The Commissioner
shall be entitled to publish the environmental reports regarding the license.
9.1 The license
owner shall meticulously follow the instructions received from a representative of the Defense Ministry, regarding any security matter
that pertains to the license area and activities according to the license.
9.2 Without derogating
from clause 9.1 above, the license owner shall act regarding security matters according to the Commissioner instructions or the officer
in charge of security at the Energy Ministry (hereinafter “the Ministry”) or the person so authorized.
10.
Supervision and Obligation to Coordinate with the Authorities.
10.1 The license
owner is responsible for receiving all legally required licenses, permits, and approvals and will act in due diligence to timely obtain
such to allow performance of the work program within the dates thereof.
10.2 Without derogating from clause 50 of the law, the
license owner shall allow the Commissioner ,or whoever has been so authorized to be present at the time of activity pursuant to the
license herein, including shall allow the Commissioner or his representatives immediate access to any place that there is activity
of the license owner and access to any data, document or any other information that they request so as to fulfill their duties.
10.3 The supervision
powers lawfully exercised, or the right to demand reports as above, shall not be deemed to hold the State or the Commissioner or anyone
on their behalf, any liability, or to create a claim of estoppel regarding performance of any activities under the license.
10.4 The supervision
powers ,or the right to demand reports as above, shall not derogate from the liability of the license owner regarding the performance
of the work plan and to fulfill all of license owner obligations according to the license and the law.
10.5 Without derogating from the license and
provisions of the law, the Commissioner is entitled to instruct the license owner to perform activities and examination that the
Commissioner in their opinion deems necessary for supervision on fulfilling the license terms and permits, including the provisions
of the law, documents, and procedures thereof: In the event that license owner has not done such within a reasonable period set by
the Commissioner, the Commissioner shall be entitled to fulfill such activity or examination by whoever the Commissioner has
authorized and the Commissioner shall be entitled to demand that the license owner provide the necessary equipment for such.
10.6 In the event
that that it has been brought to the attention of the license owner a demand of any authorized authority, that in their opinion may impair
the ability of the license owner to fulfill the terms of the license , then license owner shall immediately notify the Commissioner of
such.
11.1 The license
owner shall give preference to local Israeli manpower inasmuch as there is in Israel manpower that has the ability and qualifications
to fulfill the professional and management duties requires for the purpose of the license, at the accepted cost for such services.
11.2 The license owner shall give
preference to goods and services created in Israel when purchasing goods and services for performance of activities in the license
area, inasmuch as these conform to the quality cost and availability to goods and services created abroad.
11.3 The license
owner shall ascertain if there are local manufacturers and service providers that can supply the necessary goods and services to perform
the activities in the license area. Said ascertainment may be direct or by the relevant government offices, industrial organizations or
the Industry Authority.
The license owner shall provide a fair and equal opportunity
for local manufacturers and service providers to integrate into its license operations.
12.1 The license
owner shall act according to the environment guidelines and all of the Commissioners instructions and any government authority regarding
environment protection.
12.2 The license
owner shall not drill or perform any activity that requires receiving any required permit or approval from the planning authorities and
shall act according to such terms and conditions.
13.1 The license
owner shall pay the annual fee according to the law and regulations as set from time to time.
13.2 In the event
that the license owner shall produce oil or natural gas from the license area, the license owner shall pay the royalties to the State
of Israel according to section 32 of the law and Commissioner guidelines.
14.1 Condition
precedent for grant of the license is that the Licensee submits an autonomous irrevocable unconditional bank guarantee of $500,000 US
Dollars as set forth in the attached appendix (hereinafter” the Guarantee”).
14.2 Drilling
is subject to submission of required securities as per the law and Commissioners guidelines for submission of securities regarding oil
rights as amended from time to time.
14.3 The Guarantees
and securities shall not be deemed to limit the liability of the license owner to the State for payments that the license owner is liable
for pursuant to the license or any law, or for compensation for damages caused to the State (including any of its authorities)
14.4 The Commissioner
shall forfeit the guarantee in any case as mentioned in the guidelines for submission of guarantees regarding an oil right, and the provisions
of said guidelines shall apply to the forfeiture as mentioned.
14.5 The validity
of the license shall be subject to the existence of a valid guarantee.
14.6 The guarantee
shall remain valid also after the expiration of the license pursuant to the law and guidelines regarding guarantees.
15.1 The State
or any State authority or any employee of their employees shall not be responsible for any directives that have been given according to
authority and the law, including directives ,permits, licenses and approvals, the license and written approvals, provisions of the law
or any other directives and shall not be liable to the license owner ,their employess,contractors,clients and any other third party and
shall not be considered a cause of action for any of the above or to remove from the license owner full liability according to the law
and the license and written approvals, to perform activities in the license area in a safe and proper manner.
15.2 The authority
to grant approval or supervision according to the law or the license or the approval, or use of any other authority as per this license,
to approve or any law of the State or any of the States authorities or any of their employees shall not be deemed to place any liability
on any of the above ,that is on the license owner or remove or reduce such liability.
15.3 The license owner shall
indemnify the State, including any of its authorities or employees , for any monetary or non-monetary damage, or any financial
liability including legal expenses and other expenses, that they are liable for to a third party resulting from a negligent act or
omission, or contrary to the terms of the license or approval, of the license owner regarding the license and obligations therein as
per the license pursuant to any final judgement , to any procedure that the license owner is party to or that they were given the
opportunity to be party to, and in the event of compromise – after the license owner has approved , they shall not refuse
except for reasonable reasons.
15.4 The license
owner, at their expense , shall for the entire license period, have all the insurances set in chapter B of the guidelines for Insurance
regarding oil rights, and all of the said provisions shall apply to the license owner mutatis mutandis.
16.1 On transfer
of the license or benefit or a pledge of the license section 76 of the Law shall apply.the license or any benefit therein, cannot be pledged
or transferred in any way, except with the approval of the Commissioner.
16.2 The provisions
of section 76 of the Law shall apply to any application to transfer or pledge the license or any other benefit.
17.1 The terms
of the license shall not be deemed to derogate from the liabilities of the license owner by any law that applies to them at any time
17.2 The license
owner is obligates to act in accordance with the various guidelines and amendments made from time to time by the Commissioner on the internet
site of the Ministry.
17.3 The terms
and demands included in the license are in addition to any demands of the Commissioner or any other lawful authority.
17.4 In the event
that the license is held by more than one entity, each of the owners of the license shall be liable jointly and severally for the fulfillment
of the license terms.
17.5 The owner
of the license shall, during the entire period of the license, have the the ability to fulfill their obligations as per the license and
the law
17.6
The attachments to this license shall be considered an integral part hereof.
17.7 The license
shall be public and shall be published on the Ministry’s website.
17.8 Applications,
reports or any other documents that have to be prepared and submitted to the Commissioner shall be prepared in a professional ansd clear
manner customary in the field, and shall be submitted to the Commissioner in writing and sent by mail, by messenger ,facsimile or as a
scanned document sent by electronic mail or any other electronic format that the Commissioner requires.
17.9 Applications
and reports shall be submitted signed by the authorized person by the license owner.
17.10 The law
that shall apply to the license is Israeli law,and the courts in Israel shall have exclusive jurisdiction in all matters regarding the
license.
I, Robert W. A. Dunn, certify that:
I, Michael B. Croswell Jr, certify that:
In connection with the Quarterly Report of Zion Oil
and Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 (the “Report”), as filed with
the Securities and Exchange Commission on the date hereof, I, Robert W.A. Dunn, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
In connection with the Annual Report of Zion Oil and
Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 (the “Report”), as filed with the
Securities and Exchange Commission on the date hereof, I, Michael B. Croswell Jr., Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
Stockholders' Equity
|
9 Months Ended |
Sep. 30, 2023 |
Stockholders' Equity [Abstract] |
|
Stockholders' Equity |
Note
3 - Stockholders’ Equity
The
Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase
the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000
shares, effective June 7, 2023.
A.
2021 Omnibus Incentive Stock Option Plan
Effective
June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option
Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares
of common stock.
The
Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock,
bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments
under certain conditions.
The
compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award,
when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable
for a period not to exceed ten years from the date of grant.
During
the nine months ended September 30, 2023, the Company granted the following options from the 2021 Equity Omnibus Plan for employees,
directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000. |
| ii. | Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500. |
| iii. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through June 8, 2033. The fair value of the options at the date of grant amounted to approximately $1,500. | | iv. | Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $600. |
| v. | Options to purchase 895,000 shares of Common Stock to five staff members and one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $60,000. | | | | | vi. | Options to purchase 3,350,000 shares of Common Stock to four senior officers and nine staff members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $211,000, and will be recognized during the years 2023 and 2024. | | | | | vii. | Options to purchase 3,600,000 shares of Common Stock to nine board members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $227,000, and will be recognized during the years 2023 and 2024. | | | | | viii. | Options to purchase 55,000 shares of Common Stock to three consultants at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $3,000, and will be recognized during the years 2023 and 2024. |
During
the nine months ended September 30, 2022, the Company granted the following options from the 2021 Equity Omnibus Plan for employees,
directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase 175,000 shares of Common Stock to six senior officers and one staff member at an exercise price of $0.1529 per share. The options vested upon grant and are exercisable through January 4, 2032. The fair value of the options at the date of grant amounted to approximately $22,000. |
| ii. | Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $4,000. |
| iii. | Options to purchase 300,000 shares of Common Stock to one senior officer and one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,000. |
| iv. | Options to purchase 200,000 shares of Common Stock to one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $29,000. |
| v. | Options to purchase 1,600,000 shares of Common Stock to five senior officers and four staff members at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $209,000, and will be recognized during the years 2022 and 2023. |
| vi. | Options to purchase 1,400,000 shares of Common Stock to seven board members, at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $182,000, and will be recognized during the years 2022 and 2023. | | | | | vii. | Options to purchase 160,000 shares of Common Stock to four staff members, at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 17, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $23,000. | | | | | viii. | Options to purchase 200,000 shares of Common Stock to six staff members at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $26,000, and will be recognized during the years 2022 and 2023. | | | | | ix. | Options to purchase 40,000 shares of Common Stock to two consultants at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $5,000, and will be recognized during the years 2022 and 2023. | | x. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.11 per share. The options vested upon grant and are exercisable through April 1, 2032. The fair value of the options at the date of grant amounted to approximately $2,000. |
| xi. | Options to purchase 3,210,000 shares of Common Stock to five senior officers, two consultants and ten staff members at an exercise price of $0.15 per share. The options vested on April 15, 2023 (in one year) and are exercisable through April 15, 2032. The fair value of the options at the date of grant amounted to approximately $394,000, and will be recognized during the years 2022 and 2023. |
| xii. | Options to purchase 1,090,000 shares of Common Stock to one senior officer, one board member and five staff members at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $149,000. |
| xiii. | Options to purchase 3,200,000 shares of Common Stock to eight board members at an exercise price of $0.15 per share. The options vested on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $393,000. | | xiv. | Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.2350 per share. The options vested upon grant and are exercisable through August 1, 2032. The fair value of the options at the date of grant amounted to approximately $5,000. | | xv. | Options to purchase 118,000 shares of Common Stock to two senior officers and four staff members at an exercise price of $0.2350 per share. The options vested upon grant and are exercisable through August 12, 2032. The fair value of the options at the date of grant amounted to approximately $29,000. | | | | | xvi. | Options to purchase 75,000 shares of Common Stock to four staff members and one consultant at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through August 12, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $13,000. | | | | | xvii. | Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 01, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $2,000. | | | | | xviii. | Options to purchase 2,455,000 shares of Common Stock to four senior officers and thirteen staff members at an exercise price of $0.1797 per share. The options vest on September 23, 2023 (one year from the date of grant) and are exercisable through September 23, 2032. The fair value of the options at the date of grant amounted to approximately $396,000, and will be recognized during the years 2022 and 2023. | | | | | xix. | Options to purchase 2,700,000 shares of Common Stock to nine board members at an exercise price of $0.1797 per share. The options vest on September 23, 2023 (one year from the date of grant) and are exercisable through September 23, 2023. The fair value of the options at the date of grant amounted to approximately $436,000, and will be recognized during the years 2022 and 2023. | | | | | xx. | Options to purchase 845,000 shares of Common Stock to one senior officer, one board member and four staff members at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $149,000. | B.
Stock Options
The
stock option transactions since January 1, 2023 are shown in the table below:
| |
Number of shares | | |
Weighted Average exercise price | |
| |
| | |
US$ | |
Outstanding, December 31, 2022 | |
| 26,391,250 | | |
| 0.30 | |
| |
| | | |
| | |
Changes during 2023 to: | |
| | | |
| | |
Granted to employees, officers, directors and others | |
| 8,135,000 | | |
| 0.07 | |
Expired/Cancelled/Forfeited | |
| (275,000 | ) | |
| 1.71 | |
Exercised | |
| (150,000 | ) | |
| 0.07 | |
Outstanding, September 30, 2023 | |
| 34,101,250 | | |
| 0.23 | |
Exercisable, September 30, 2023 | |
| 27,096,250 | | |
| 0.27 | |
The
following table summarizes information about stock options outstanding as of September 30, 2023:
Shares
underlying outstanding options (non-vested) |
|
|
Shares
underlying outstanding options (fully vested) |
|
Range
of
exercise
price |
|
|
Number
outstanding |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Weighted
Average
Exercise
price |
|
|
Range
of
exercise
price |
|
|
Number
Outstanding |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Weighted
Average
Exercise
price |
|
US$ |
|
|
|
|
|
|
|
|
US$ |
|
|
US$ |
|
|
|
|
|
|
|
|
US$ |
|
|
0.07 |
|
|
|
7,005,000 |
|
|
|
9.99 |
|
|
|
0.07 |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
0.12 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
5,000 |
|
|
|
0.70 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
20,000 |
|
|
|
2.68 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
130,000 |
|
|
|
3.26 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
50,000 |
|
|
|
3.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
60,000 |
|
|
|
3.55 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
200,000 |
|
|
|
3.64 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
40,000 |
|
|
|
4.01 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
70,000 |
|
|
|
4.26 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
4.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
30,000 |
|
|
|
4.42 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
4,000 |
|
|
|
4.52 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
5.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
35,000 |
|
|
|
5.97 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
150,000 |
|
|
|
6.14 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
35,000 |
|
|
|
6.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
75,000 |
|
|
|
7.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
200,000 |
|
|
|
7.64 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
300,000 |
|
|
|
7.80 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
7.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
500,000 |
|
|
|
8.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
55,000 |
|
|
|
8.30 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
960,000 |
|
|
|
8.55 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
75,000 |
|
|
|
8.87 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
8.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
795,000 |
|
|
|
8.99 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
25,000 |
|
|
|
9.27 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
10,000 |
|
|
|
9.93 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
895,000 |
|
|
|
9.99 |
|
|
|
0.01 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.06 |
|
|
|
50,000 |
|
|
|
9.27 |
|
|
|
0.06 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.07 |
|
|
|
25,000 |
|
|
|
9.70 |
|
|
|
0.07 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.14 |
|
|
|
240,000 |
|
|
|
8.31 |
|
|
|
0.14 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.15 |
|
|
|
3,200,000 |
|
|
|
8.27 |
|
|
|
0.15 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.15 |
|
|
|
6,410,000 |
|
|
|
8.55 |
|
|
|
0.15 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.16 |
|
|
|
340,000 |
|
|
|
2.20 |
|
|
|
0.16 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.16 |
|
|
|
75,000 |
|
|
|
6.20 |
|
|
|
0.16 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.18 |
|
|
|
25,000 |
|
|
|
2.18 |
|
|
|
0.18 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.18 |
|
|
|
5,155,000 |
|
|
|
8.99 |
|
|
|
0.18 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.24 |
|
|
|
25,000 |
|
|
|
8.84 |
|
|
|
0.24 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.24 |
|
|
|
118,000 |
|
|
|
8.87 |
|
|
|
0.24 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.25 |
|
|
|
50,000 |
|
|
|
7.93 |
|
|
|
0.25 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.25 |
|
|
|
363,000 |
|
|
|
7.93 |
|
|
|
0.25 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.28 |
|
|
|
25,000 |
|
|
|
1.93 |
|
|
|
0.28 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.28 |
|
|
|
25,000 |
|
|
|
5.93 |
|
|
|
0.28 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.29 |
|
|
|
25,000 |
|
|
|
3.71 |
|
|
|
0.29 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.39 |
|
|
|
1,435,000 |
|
|
|
7.78 |
|
|
|
0.39 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.59 |
|
|
|
1,400,000 |
|
|
|
3.64 |
|
|
|
0.59 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.59 |
|
|
|
1,600,000 |
|
|
|
7.64 |
|
|
|
0.59 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.92 |
|
|
|
350,000 |
|
|
|
3.27 |
|
|
|
0.92 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.92 |
|
|
|
550,000 |
|
|
|
7.27 |
|
|
|
0.92 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.38 |
|
|
|
105,307 |
|
|
|
1.26 |
|
|
|
1.38 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.67 |
|
|
|
405,943 |
|
|
|
1.01 |
|
|
|
1.67 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.78 |
|
|
|
25,000 |
|
|
|
0.93 |
|
|
|
1.78 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2.31 |
|
|
|
250,000 |
|
|
|
0.25 |
|
|
|
2.31 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4.15 |
|
|
|
25,000 |
|
|
|
0.76 |
|
|
|
4.15 |
|
|
0.07 |
|
|
|
7,005,000 |
|
|
|
|
|
|
|
0.07 |
|
|
|
0.01-4.15 |
|
|
|
27,096,250 |
|
|
|
|
|
|
|
0.27 |
|
Granted
to employees
The
following table sets forth information about the weighted-average fair value of options granted to employees and directors during the
year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
| |
For the nine months ended September 30, | |
| |
2023 | | |
2022 | |
Weighted-average fair value of underlying stock at grant date | |
$ | 0.07 | | |
$ | 0.16 | |
Dividend yields | |
| — | | |
| — | |
Expected volatility | |
| 135%-137 | % | |
| 127%-135 | % |
Risk-free interest rates | |
| 3.85%-4.61 | % | |
| 1.37%-3.96 | % |
Expected lives (in years) | |
| 5.00-5.50 | | |
| 5.00-5.50 | |
Weighted-average grant date fair value | |
$ | 0.06 | | |
$ | 0.14 | |
Granted
to non-employees
The
following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using
the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
| |
For the nine months ended
September 30, | |
| |
2023 | | |
2022 | |
Weighted-average fair value of underlying stock at grant date | |
| 0.07 | | |
$ | 0.16 | |
Dividend yields | |
| — | | |
| — | |
Expected volatility | |
| 134 | % | |
| 103% - 104 | % |
Risk-free interest rates | |
| 4.61 | % | |
| 1.78% - 2.84 | % |
Expected lives (in years) | |
| 10 | | |
| 10 | |
Weighted-average grant date fair value | |
| 0.06 | | |
$ | 0.15 | |
The
risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected
life of the options.
The
expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of
the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin
No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules,
as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees
equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended
life. C.
Compensation Cost for Warrant and Option Issuances
The
following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
264 |
|
|
|
510 |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
921 |
|
|
|
1,142 |
|
The
following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
8 |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
2 |
|
|
|
11 |
|
The
following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and
capitalized to Unproved Oil & Gas properties:
For
the three months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
— |
|
For
the nine months ended September 30, |
|
2023 |
|
|
2022 |
|
US$
thousands |
|
|
US$
thousands |
|
|
— |
|
|
|
17 |
|
The
following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and
capitalized to Unproved Oil & Gas properties:
As
of September 30, 2023, there was $431,000 of unrecognized compensation cost related to non-vested stock options granted under the Company’s
various stock option plans. That cost is expected to be recognized during the remaining periods of 2023 and 2024. D.
Dividend Reinvestment and Stock Purchase Plan (“DSPP”)
On
March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with
the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014.
On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration
No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The
Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed
and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and
replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.
On
March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders
and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly
from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original
Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration
Statement on Form S-3, as thereafter amended.
On
January 13, 2015, the Company amended the Original Prospectus Supplement (“Amendment No. 3”) to provide for a unit option
(the “Unit Option”) under the DSPP comprised of one share of Common Stock and three Common Stock purchase warrants with each
unit priced at $4.00. Each warrant afforded the participant the opportunity to purchase the Company’s Common Stock at a warrant
exercise price of $1.00. Each of the three warrants series had different expiration dates that had been extended.
The
ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018,
at a per share exercise price of $1.00.
As
of May 2, 2017, any outstanding ZNWAB warrants expired.
As
of May 2, 2018, any outstanding ZNWAC warrants expired.
On
May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020
to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2,
2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension.
As
of May 2, 2023, any outstanding ZNWAD warrants expired.
On
November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units
comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant
is referred to as “ZNWAE.”
The
ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of
$1.00.
On
May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020
to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1,
2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension. As
of May 1, 2023, any outstanding ZNWAE warrants expired.
On
May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants,
a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions
and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase
Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common
Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common
Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares
of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.”
All
ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise
price of $1.00.
On
May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020
to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August
14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of August 14, 2023, any outstanding ZNWAF warrants expired.
An
Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017.
Under
Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants
to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of
shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s
Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15
shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”
The warrants became exercisable on January 8,
2018 and continue to be exercisable through January 8, 2023 at a revised per share exercise price of $.25. The warrant terms provide that
if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior
to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing
60 days advanced notice to the warrant holders. On
December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January
8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
On
February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units
of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase
warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares
of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase
one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”
The
warrants became exercisable on April 2, 2018 and continued to be exercisable through April 2, 2020 at a per share exercise price of $5.00,
after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April
2, 2019 to April 2, 2020.
On
May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 2, 2020
to April 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April
2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
As
of April 2, 2023, any outstanding ZNWAH warrants expired.
On
August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units
of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common
Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly
traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional
twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s
Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common
Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.”
The
warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price
of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date
of October 29, 2019 to October 29, 2020.
On
May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29,
2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October
29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
On
December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units
of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of
Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at
a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s
Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase
one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The
warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price
of $0.01.
On
May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25,
2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension.
On
September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February
25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of February 25, 2023, any outstanding ZNWAK warrants expired.
On
April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended
the termination date of the unit offering.
The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two
hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of
Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the
Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program
with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at
a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit
Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were
entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant
affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is
referred to as “ZNWAL.”
The
warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price
of $2.00.
On
September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August
26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension.
As
of August 26, 2023, any outstanding ZNWAL warrants expired.
Under our Plan, the Company under a Request For
Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities
and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with
the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity
to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.”
The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable
on January 15, 2021 and continued to be exercisable through July 15, 2022.
On
March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022
to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such,
there is no value assigned to this extension.
On
June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion
considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the
termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per
ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the
number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase
an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited
with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants
who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments
(“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of
$1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers
to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the
Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $1.00. The warrant is referred to as “ZNWAN.”
The
warrants became exercisable on May 16, 2021 and continued to be exercisable through May 16, 2023 at a per share exercise price of $1.00.
As
of May 16, 2023, any outstanding ZNWAN warrants expired.
On
April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.
The
unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the
number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase
an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited
with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants
who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments
(“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price
of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers
to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the
Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $.25. The warrant is referred to as “ZNWAO.”
The
warrants became exercisable on June 12, 2021 and continued to be exercisable through June 12, 2023 at a per share exercise price of $.25.
As
of June 12, 2023, any outstanding ZNWAO warrants expired.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to
a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of
shares of the Company’s Common Stock that were acquired.
Under our Plan, the Company under a Request For
Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After
conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s
Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common
Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be
registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable
through July 15, 2023 at a revised per share exercise price of $.05. Zion
considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On
June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On August 21, 2023, the Company extended the termination
date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.
As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the
termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per
ASC 815-40-35-2. As such, there is no value assigned to this extension.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program
on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock
that were acquired.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation
of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised
per share exercise price of $.25.
On
December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose
of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus
that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein.
On
December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting
the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus
that forms a part of the Registration Statement and accordingly such prospectus has not been included herein.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation
of “ZNWAT.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per
share exercise price of $.25.
Under
our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares
of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant
the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation
of “ZNWAU.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The
warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per
share exercise price of $.25.
Under our Plan, the Company under a Request For
Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program
on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that
were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed
two additional Waiver Term Sheets with the same participant consisting of shares of stock. After conclusion of the program on December
31, 2023, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock that were
acquired. During the quarter ended September 30, 2023, Zion incurred an additional $437,000 in equity issuance costs bringing the YTD
total to approximately $610,000.
On
March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December
15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock
Purchase Plan. This Amendment No. 2 to Prospectus Supplement amended the Prospectus Supplement. The Prospectus forms a part of the Company’s
Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15,
2021. Amendment
No. 2 - New Unit Option under the Unit Program
Under
our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants
with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment
No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This
Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total
of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13,
2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche
began on April 10, 2023 and terminated on April 27, 2023.
The
Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares
of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s
publicly traded common stock as reported on the OTCQX on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an
additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was
credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each
warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant
shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX”
under the third tranche.
Plan
participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly
Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price
of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the
Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they
purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received
one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and
fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY
warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to
participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.
The
ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price
of $0.05.
As
of June 28, 2023, any outstanding ZNWAV warrants expired.
The
ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price
of $0.05.
As
of July 13, 2023, any outstanding ZNWAW warrants expired.
The
ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price
of $0.05.
On
July 31, 2023, any outstanding ZNWAX warrants expired.
The
ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise
price of $0.05.
On
September 10, 2023, any outstanding ZNWAY warrants expired.
Amendment
No. 3 – New Unit Option under the Unit Program
Under
our Plan, provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.
Our
Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined
in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price
and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May
15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each)
was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average
of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQX on the Unit Purchase Date
and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price
of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants
that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common
Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered
for trading on the OTCQX or any other stock market or trading market. Plan
participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly
Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise
price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and
received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional
three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.
The ZNWAZ warrants became exercisable on July
17, 2023 and continue to be exercisable through July 17, 2024 at a per share exercise price of $0.25.
Amendment No. 4 – New Unit Option under
the Unit Program
Under our Plan, we are providing a Unit Option
under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and terminates on December 31, 2023.
Our Unit Program consists of the combination of
Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment
No. 1. Amendment No. 4 provides the option period, unit price and the determination of the number of shares of Common Stock and warrants
per unit. This Unit Option began on November 6, 2023 and is scheduled to terminate on December 31, 2023, unless extended at the sole discretion
of Zion Oil & Gas, Inc. The Unit Option consists of Units of our securities where each Unit (priced at $250.00 each) is comprised
of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and
low sale prices of the Company’s publicly traded common stock as reported on the OTCQX on the Unit Purchase Date and (ii) Common
Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s
Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units
purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price
of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQX or any
other stock market or trading market.
Plan participants, who enroll into the Unit Program
with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum
of $50.00 per month, will receive an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The
fifty (50) additional warrants are for enrolling into the AMI program and shall receive the above warrant with the Company notation of
“ZNWBA.” Existing subscribers to the AMI are entitled to the additional fifty (50) warrants, if they purchase at least one
(1) Unit during the Unit program.
The ZNWBA warrants will become exercisable on
January 15, 2024, unless extended, and continue to be exercisable through January 14, 2025, unless extended, at a per share exercise price
of $0.25.
For
the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program,
respectively. The $4,358,000 figure is net of $610,000 in equity issuance costs to an outside party.
For
the three and nine months ended September 30, 2022, approximately $3,477,000, and $16,470,000 were raised under the DSPP program,
respectively.
The company raised approximately $391,000 from the period October
1, 2023 through November 7, 2023, under the DSPP program.
The
warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other
warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification
and accounting purposes only. E.
Warrant Table
The
warrants balances at December 31, 2022 and transactions since January 1, 2023 are shown in the table below:
Warrants | |
Exercise Price | | |
Warrant Termination Date | |
Outstanding Balance, 12/31/2022 | | |
Warrants Issued | | |
Warrants Exercised | | |
Warrants Expired | | |
Outstanding Balance, 9/30/2023 | |
ZNWAA | |
$ | 2.00 | | |
01/31/2024 | |
| 1,498,804 | | |
| - | | |
| - | | |
| - | | |
| 1,498,804 | |
ZNWAD | |
$ | 1.00 | | |
05/02/2023 | |
| 243,853 | | |
| - | | |
| - | | |
| (243,853 | ) | |
| - | |
ZNWAE | |
$ | 1.00 | | |
05/01/2023 | |
| 2,144,099 | | |
| - | | |
| - | | |
| (2,144,099 | ) | |
| - | |
ZNWAF | |
$ | 1.00 | | |
08/14/2023 | |
| 359,435 | | |
| - | | |
| - | | |
| (359,435 | ) | |
| - | |
ZNWAG | |
$ | 1.00 | | |
01/08/2024 | |
| 240,068 | | |
| - | | |
| - | | |
| - | | |
| 240,068 | |
ZNWAH | |
$ | 5.00 | | |
04/19/2023 | |
| 372,400 | | |
| - | | |
| - | | |
| (372,400 | ) | |
| - | |
ZNWAI | |
$ | 3.00 | | |
06/29/2023 | |
| 640,710 | | |
| - | | |
| (100 | ) | |
| (640,610 | ) | |
| - | |
ZNWAJ | |
$ | 1.00 | | |
10/29/2023 | |
| 545,900 | | |
| - | | |
| - | | |
| - | | |
| 545,900 | |
ZNWAK | |
$ | 0.01 | | |
02/25/2023 | |
| 424,225 | | |
| - | | |
| (9,050 | ) | |
| (415,175 | ) | |
| - | |
ZNWAL | |
$ | 2.00 | | |
08/26/2023 | |
| 517,875 | | |
| - | | |
| - | | |
| (517,875 | ) | |
| - | |
ZNWAM | |
$ | 0.05 | | |
12/31/2023 | |
| 4,376,000 | | |
| - | | |
| - | | |
| - | | |
| 4,376,000 | |
ZNWAN | |
$ | 1.00 | | |
05/16/2023 | |
| 267,760 | | |
| - | | |
| (75 | ) | |
| (267,685 | ) | |
| - | |
ZNWAO | |
$ | 0.25 | | |
06/12/2023 | |
| 174,660 | | |
| - | | |
| - | | |
| (174,660 | ) | |
| - | |
ZNWAQ | |
$ | 0.05 | | |
12/31/2023 | |
| 23,428,348 | | |
| - | | |
| - | | |
| - | | |
| 23,428,348 | |
ZNWAV | |
$ | 0.05 | | |
06/28/2023 | |
| - | | |
| 288,500 | | |
| (167,730 | ) | |
| (120,770 | ) | |
| - | |
ZNWAW | |
$ | 0.05 | | |
07/13/2023 | |
| - | | |
| 199,000 | | |
| (151,500 | ) | |
| (47,500 | ) | |
| - | |
ZNWAX | |
$ | 0.05 | | |
07/31/2023 | |
| - | | |
| 818,500 | | |
| (458,750 | ) | |
| (359,750 | ) | |
| - | |
ZNWAY | |
$ | 0.05 | | |
09/10/2023 | |
| | | |
| 17,450 | | |
| (3,700 | ) | |
| (13,750 | ) | |
| - | |
ZNWAZ | |
$ | 0.25 | | |
07/17/2024 | |
| - | | |
| 153,500 | | |
| - | | |
| - | | |
| 153,500 | |
Outstanding warrants | |
| | | |
| |
| 35,234,137 | | |
| 1,476,950 | | |
| (790,905 | ) | |
| (5,677,562 | ) | |
| 30,242,620 | |
F.
Warrant Descriptions of Current Warrants
The
price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those
warrants with an expiration date beyond the balance sheet date.
|
|
|
|
Period of Grant |
|
US$ |
|
|
Expiration Date |
ZNWAA Warrants |
|
A,B,E |
|
March 2013 – December 2014 |
|
|
2.00 |
|
|
January 31, 2024 |
ZNWAG Warrants |
|
B,E |
|
October 2017 – December 2017 |
|
|
1.00 |
|
|
January 08, 2024 |
ZNWAJ Warrants |
|
A,B |
|
August 2018 – September 2018 |
|
|
1.00 |
|
|
October 29, 2023 |
ZNWAM Warrants |
|
C,F |
|
January 2021 – March 2021 |
|
|
0.05 |
|
|
December 31, 2023 |
ZNWAQ Warrants |
|
C,F |
|
June 2021 |
|
|
0.05 |
|
|
December 31, 2023 |
ZNWAS Warrants |
|
D |
|
August 2021 – March 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAT Warrants |
|
D |
|
August – September 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAU Warrants |
|
D |
|
October – November 2022 |
|
|
0.25 |
|
|
December 31, 2025 |
ZNWAZ Warrants |
|
G |
|
May – June 2023 |
|
|
.25 |
|
|
July 17, 2024 |
ZNWBA Warrants |
|
H |
|
November – December 2023 |
|
|
.25 |
|
|
January 15, 2025 |
A | On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year. | | | B | On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years. | | | C | On
March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the
expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants
to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023. | | | D | These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025. | | | E | On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year. | | | F | The warrant exercise price was lowered to $0.05 on December 28, 2022. | | | G | On May 15, 2023, the Company announced a new Unit Offering and the related ZNWAZ warrant. | | | H | On November 6, 2023 the Company announced a new Unit Offering and the
related ZNWBA warrant.
|
|